0001079974-20-000021.txt : 20200114 0001079974-20-000021.hdr.sgml : 20200114 20200114150800 ACCESSION NUMBER: 0001079974-20-000021 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20191130 FILED AS OF DATE: 20200114 DATE AS OF CHANGE: 20200114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MCTC Holdings, Inc. CENTRAL INDEX KEY: 0001413488 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 831754057 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-146404 FILM NUMBER: 20525894 BUSINESS ADDRESS: STREET 1: 520 S. GRAND AVENUE STREET 2: SUITE 320 CITY: LOS ANGELES STATE: CA ZIP: 90071 BUSINESS PHONE: (310) 986-4929 MAIL ADDRESS: STREET 1: 520 S. GRAND AVENUE STREET 2: SUITE 320 CITY: LOS ANGELES STATE: CA ZIP: 90071 FORMER COMPANY: FORMER CONFORMED NAME: MICROCHANNEL TECHNOLOGIES CORP DATE OF NAME CHANGE: 20070925 10-Q 1 mctc10qn_11302019.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

  


 

FORM 10-Q

(Mark One)

 

  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended November 30, 2019

 

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File Number: 000-27039

 

MCTC HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   83-1754057
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
520 S. Grand Avenue, Suite 320    
Los Angeles, CA   90071
(Address of principal executive offices)   (Zip Code)

 

(310) 986-4929

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes     No 

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer  
           
Non-accelerated filer (Do not check if a smaller reporting company)   Smaller reporting company  
           

Emerging growth company

 

       

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o    No ý

 

 

As of November 30, 2019, and January 14, 2020, there were 14,833,128 and 15,093,128 shares of the registrant’s common stock outstanding, respectively.

 

 

 1 
 

 

MCTC HOLDINGS, INC. 

FORM 10-Q

 

For the Period Ended November 30, 2019

 

Table of Contents

  

PART I  FINANCIAL INFORMATION
   
Item 1. Financial Statements  
   
Condensed consolidated balance sheets as of November 30, 2019 (unaudited)
and August 31, 2019 (audited)
3
Condensed consolidated statements of operations for the three months ended
November 30, 2019 and 2018 (unaudited)
4

Condensed consolidated statements of equity for the three months ended

November 30, 2019 and 2018 (unaudited)

5

 

Condensed consolidated statements of cash flows for the three months ended

November 30, 2019 and 2018 (unaudited)

6
   

Notes to Condensed Consolidated Financial Statements (unaudited)

7
   
Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations 19
   
Item 4.  Controls and Procedures 19
   
PART II  OTHER INFORMATION
   
Item 1. Legal Proceedings 25
   
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25
   
Item 3. Defaults Upon Senior Securities 25
   
Item 4. Mine Safety Disclosures 25
   
Item 5. Other Information 25
   
Item 6. Exhibits 25
   
Signatures 26
   
Certifications  

 

 

 

 2 
 

 

 

PART I — FINANCIAL INFORMATION

 

 

 

MCTC Holdings, Inc.

CONSOLIDATED BALANCE SHEETS

 

    November 30,    August 31 
    2019    2019 
    (unaudited)    (audited) 
ASSETS          
  Current Assets:          
  Cash  $64,702   $152,082 
  Accounts Receivable   5,000    - 
  Accounts Receivable – Related Party   5,003    - 
  Inventory   17,931    2,299 
Total Current Assets   92,636    152,082 
           
Machinery & Equipment- Net   12,550    13,248 
           
Other Assets          
  Notes Receivable – Related Party   40,000    40,000 
  Rent Deposit   7,200    7,200 
  Stock Subscription Receivable   65,000    - 
           
TOTAL ASSETS  $217,386   $214,829 
           
           
LIABILITIES & STOCKHOLDER'S DEFICIT          
  Current Liabilities:          
  Accounts Payable  $197,635   $92,806 
  Accounts Payable - Related Party   1,139    1,139 
  Accrued Interest   92    - 
  Accrued Professional and Legal Expenses   -    5,885 
  Accrued Research and Development Expenses   -    6,250 
  Convertible Notes, Net of Debt Discount of $17,363 and $0, respectively   35,971    33,334 
  Derivative Liability   16,018    - 
  Notes Payable - Related Party   14,000    14,000 
  Total Current Liabilities   264,855    153,414 
           
  Total Liabilities   264,855    153,414 
           
  Stockholder's Deficit          
  Preferred Stock, par value $0.0001,          
      10,000,000 shares Authorized,  0 shares Issued and          
       Outstanding at November 30, 2019 and August 31, 2019   -    - 
  Common Stock, par value $0.001,          
      290,000,000 shares Authorized,  14,833,128 shares Issued and          
      Outstanding at November 30, 2019 and 12,713,129 at August 31,   2019   1,483    1,253 
  Additional Paid-In Capital   1,464,060    1,184,923 
  Shares to be issued   26    2,840 
  Accumulated Deficit   (1,513,038)   (738,004)
           
  Total Stockholder's Deficit   (47,469)   61,415 
           
TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT  $217,386   $214,829 
           

 

 

  The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 

 3 
 

 

MCTC Holdings, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

Unaudited 

 

   For the Quarter Ended
   November, 30
   2019  2018
       
Revenue:          
   Product Sales  $5,003   $- 
   Consulting Revenue – Related Party   5,000    - 
Total Revenue   10,003    - 
           
Cost of Goods Sold   2,900    - 
Gross Profit   7,103    - 
           
Operating Expenses:          
     Advertising Expenses   1,432    - 
    Consulting Services   35,883    - 
    Professional Fees   148,955    12,500 
    General and Administrative Expenses   187,523    2,261 
 Total Operating Expenses   373,793    14,761 
           
Operating Loss   (366,690)   (14,761)
           
Other  Income (Expense)          
Interest Expense   (31,250)   (2,522)
Changes in FV of Derivative   12,503    - 
Total Other Income (Expense)   (18,747)   (2,522)
           
 Net Loss  $(385,437)  $(17,283)
           
 Basic & Diluted Loss per Common Share  $(0.03)  $(0.00)
           
 Weighted Average Common Shares          
 Outstanding   12,752,506    12,257,640 
           

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 

 4 
 

 

MCTC HOLDINGS INC AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT

FOR THE THREE MONTHS ENDED NOVEMBER 30, 2019 AND 2018

                     Additional      
   Class A Preferred Stock  Common Stock  Common Stockd n mulated   
   Shares  Amount  Shares  Amount  Shares  Amount  Capital  Deficit  Total
Balance, August 31, 2018   -   $1    12,257,640   $1,226    -   $-   $601,825   $(738,004)  $(134,953)
                                              
Net loss   -    -    -    -    -    -    -    (17,283)   (17,283)
                                              
Balance, November 30, 2018   -   $-    12,257,640   $1,226   $-   $-   $601,825   $(755,287)  $(152,236)
Stock based compensation   -    -    -    -    -    -    95,670    -    95,670 
Proceeds from shares issued in private placement   -    -    203,333    20    -    -    74,980    -    75,000 
Proceeds from shares issued in private placement- to be issued   -    -    -    -    260,000    26    64,974    -    65,000 
Discount on convertible note   -    -    -    -    -    -    20,000    -    20,000 
Stock split adjustment   -    -    188,822    19    -    -    (19)          
Net loss   -    -    -    -    -    -    -    (385,437)   (385,437)
                                              
Balance, November 30, 2019   -   $-    392,155   $39   $260,000   $26   $255,605   $(385,437)  $(129,767)

 

 

 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 

 

 5 
 

 

 

MCTC Holdings, Inc.

CONSOLIDATED STATEMENTS OF CASHFLOWS

Unaudited 

 

   For the Quarter Ended
   November 30,
   2019  2018
CASH FLOWS FROM OPERATING          
ACTIVITIES:          
Net Loss  $(385,437)  $(17,283)
 Adjustments to reconcile net loss to net cash          
 used in operating activities:          
   Non-cash interest expense   31,158    - 
   Depreciation expense   698    - 
   Stock based compensation   116,553    - 
   Change in fair value of derivative liability   (12,503)     
Changes In:          
   Account Receivable   (10,003)   - 
    Inventory   (15,632)   - 
   Accounts Payable   104,829    (1,070)
   Accrued Interest   92    1,745 
   Accrued Interest - Related Party   -    777
   Accrued Professional and Legal Expenses   (5,885)   - 
   Accrued R&D Expenses   (6,250)   - 
Accounts Payable - Related Party   -    500 
Net Cash Used in Operating Activities   (182,380)   (15,331)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
           
Net Cash Provided by Investing Activities   -    - 
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
  Proceeds from issuance of common stock   75,000    - 
  Proceeds from convertible debentures   20,000    -
  Proceeds from Note Payable - Related Party   -    15,356 
Net Cash Provided by Financing Activities   95,000    15,356 
           
Net (Decrease) Increase in Cash   (87,380)   25 
Cash at Beginning of Period   152,082    4,652 
           
Cash at End of Period  $64,702   $4,677 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid during the year for:          
Interest  $-   $- 
Franchise Taxes  $-   $- 

 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

 

 6 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

Note 1. Organization and Description of Business

 

MCTC Holdings, Inc. is located at 520 S Grand Avenue, Suite 320, Los Angeles, California 90071. Our telephone number is (310) 986-4929 and our website is accessible at www.cannabisglobalinc.com. Our shares of Common Stock are quoted on the OTC Markets Pink, operated by OTC Markets Group, Inc., under the ticker symbol “MCTC.” We are a research and development company focused on cannabinoid research.

Our aim is to create and commercialize proprietary engineered technologies to deliver hemp extracts and cannabinoids to the human body. Additionally, we plan to develop consumer products, based on these and other proprietary technologies.

Our R&D programs included the following;

  1) Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.

 

  2) Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.

 

  3) Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.

 

  4) Establishment of new methods to increase the bioavailability of cannabinoids to the human body through utilization of proven bioenhancers, including d-α-Tocopherol polyethylene glycol 1000 succinate (TPGS), which is widely used as a water-soluble vitamin E formulation.

 

  5) Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.

 

On August 9, 2019, our board of directors determined the Company no longer meets the definition of a Shell Company as defined in Item 1101(b) of Regulation AB ( § 229.1101(b) of this chapter), which defines a Shell Company as one that has: 1) No or nominal operations; and 2) Either: (i) No or nominal assets; (ii) Assets consisting solely of cash and cash equivalents; or (iii) Assets consisting of any amounts of cash and cash equivalents and nominal other assets. By way of the Company: 1) beginning business activities and operations, 2) hiring its CEO, 3) appointing a highly experienced board of directors, 4) retaining consultants, 5) signing two property leases, 6) approval of budgets and business plans for several initiatives, 7) production of product samples, 8) sales initiatives to prospective customers, and other related business activities, the board of directors believes such activities are qualified as non-nominal operations and therefore the board of directors declared its believe the Company is no longer defined by Item 1101(b) of Regulation AB ( § 229.1101(b) of this chapter).

On August 9, 2019, the Company filed a DBA in California registering the operating name Cannabis Global. On July 1, 2019, the Company acquired Action Nutraceuticals, Inc., a company owned by our current CEO, Arman Tabatabaei. The transaction value was nominal, at only One Thousand Dollars ($1,000). Therefore, the Company believes its acquisition of Action Nutraceuticals, Inc. is not an acquisition of a significant amount of assets, or a transaction defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, that would require specific disclosures under the section cited. Regardless, the Company will disclose the transaction pursuant to 17 CFR § 229.404 - (Item 404) “Transactions with Related Persons, Promoters and Certain Control Persons.” No intellectual property, patents or trademarks were acquired in the transaction.

On July 1, 2019, the Company entered into a 100% business acquisition with Action Nutraceuticals, Inc., a company owned by our CEO, Arman Tabatabaei. The value of the transaction value was nominal, at only One Thousand Dollars ($1,000) thus, the Company believes the business acquisition of Action Nutraceuticals, Inc. is transaction NOT defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons that would require specific disclosure under the section cited. Regardless, of the requirements of 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, the Company makes this disclosure.

 7 
 

  

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

On or about June 27, 2018 we changed domiciles from the State of Nevada to the State of Delaware and thereafter reorganized under the Delaware Holding Company Statute Delaware General Corporation Law Section 251(g). On or about July 12, 2018, two subsidiaries were formed for the purpose of effecting the reorganization. We incorporated MCTC Holdings, Inc. and MCTC Holdings Inc. incorporated MicroChannel Corp. We then effected a merger involving the three constituents and under the terms of the merger we were merged into MicroChannel Corp., with MicroChannel Corp. surviving and our separate corporate existence ceasing. Following the merger MCTC Holdings, Inc. became the surviving publicly traded issuer and all of our assets and liabilities were merged into MCTC Holdings, Inc.’s wholly owned subsidiary MicroChannel Corp. Our shareholders became the shareholders of MCTC Holdings, Inc. on a one for one basis.

On May 25, 2019, Lauderdale Holdings, LLC, a Florida limited liability company, in which former Chief Executive Officer, Garry McHenry maintains a controlling interest, sold 8,666,667 common shares of MCTC Holdings, Inc., representing approximately 70.7% of the 12,257,640 issued and outstanding shares to Messrs. Robert Hymers, Edward Manolos and Dan Nguyen, all of whom were previously unaffiliated parties. Each purchased 2,888,889 common shares for $108,333.33 each or an aggregate of $325,000, utilizing personal funds. This series of transactions constitute a change in control of the Company. The assets and liabilities of MicroChannel Corp. were spun out to Lauderdale Holdings, LLC as part of the change in control.

On January 14, 2009, Octillion Corp. (Symbol: OCTL), the parent company of MicroChannel announced that it had changed its name to New Energy Technologies, Inc. (Symbol: NENE) (“New Energy”). The name change became effective on the Over-the-Counter Bulletin Board at the opening of trading on January 14, 2009. On June 24, 2008, MicroChannel announced that it initiated trading of its stocks on the OTC Bulletin Board under the stock symbol “MCTC”. On August 22, 2007, by corporate action taken by MicroChannel’s executive team and board members, the company amended its Articles of Incorporation to increase its authorized capital stock to 300,000,000 million shares of common stock, $0.0001 par value per share. As of September 25, 2007, there were 1,000,000 shares of common stock were issued and outstanding; there were no preferred shares issued and outstanding. The directors and sole shareholder have approved a forward split of their issued and outstanding shares of common stock on the basis of 538,646 for 1 for the purpose of effecting the distribution.

On April 4, 2005, MultiChannel changed its name to MicroChannel Technologies Corporation. The Company’s original name was MultiChannel Technologies Corporation (“MultiChannel”) which was incorporated on February 28, 2005 under the laws of the State of Nevada (U.S.A.) and was originally formed as a wholly-owned subsidiary of Octillion Corp. (“Octillion”). Octillion (a Canadian company was trading in the OTC Markets under the symbol “OCTL”). At the time of Octillion’s existence, Octillion was a development stage technology company focused on the identificati0n, acquisition and development of emerging solar energy and solar related technologies and products.

Note 2. Going Concern Uncertainties

 

During recent financial reporting periods, the Company began reporting revenue and has been active in reorganizing its business operations, these revenues being generated are nominal. The Company has an accumulated deficit of $1,513,038 as of November 30, 2019, and does not have positive cash flows from operating activities. The Company expects to incur additional losses as it executes its business strategy in the cannabinoid marketplace. The Company will be subject to the risks, uncertainties, and difficulties frequently encountered by early-stage companies. The Company may not be able to successfully address any or all of these risks and uncertainties. Failure to adequately do so could cause the Company’s business, results of operations, and financial condition to suffer. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance date of these financial statements.

The Company’s ability to continue as a going concern is an issue due to its net losses and negative cash flows from operations, and its need for additional financing to fund future operations. Management plans to obtain necessary funding from outside sources and through the sales of Company shares. There can be no assurance that such funds, if available, can be obtained on terms reasonable to the Company. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that may result from the outcome of this uncertainty.

Based on the Company’s current level of expenditures, management believes that cash on hand is not adequate to fund operations for the next twelve months. Management of the Company is estimating approximately $1,000,000 will be required over the next twelve months to fully execute its business strategy. These can be no assurance the Company will be able to obtain such funds.

 8 
 

  

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

Note 3.  Summary of Significant Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties, and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies described below have the most significant impact on our consolidated financial statements.

 

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

 

Derivative Instruments 

The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense).

 

Our Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.

 

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.

 

Inventory

Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of November 30, 2019 and November 30, 2018, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.

 

Deposits

Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of November 30, 2019 or November 30, 2018.

 

 9 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

Accounts Receivable

Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of November 30, 2019 and November 30, 2018, we had $0 and $0 allowance for doubtful accounts, respectively.

 

Property and Equipment, net

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”

 

Accounting for the Impairment of Long-Lived Assets

We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. We have not recorded any impairment charges related to long-lived assets during the quarter ended November 30, 2019, and November 30, 2018.

 

Beneficial Conversion Feature

If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.

 

 10 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

 

Revenue Recognition

For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.

 

In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.

 

Product Sales

Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. Generally, we drop-ship orders to our clients with shipping-point or destination terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.

 

Costs of Revenues

Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Stock-Based Compensation

Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. We had no stock-based compensation during the year ended November 30, 2019.

 

Income Taxes

We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending November 30, 2018, and November 30, 2019, we incurred no income taxes and had no liabilities related to federal or state income taxes.

 

 11 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

 

Loss Contingencies

From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.

 

Net Income (Loss) Per Common Share

We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

 

 

 12 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

Note 4. Net Loss Per Share

 

During the financial reporting period ending November 30, 2019, the Company recorded a net loss of $385,437, which equals a loss of $0.03 on both a basic and fully diluted basis, per common share.

 

Note 5. Notes Receivable – Related Party

 

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Receivable, Related Party and in the footnote outlining Related Party Transactions. These notes are additionally described herein in Footnote 6- Notes to Shareholders, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

 

On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

 

Note 6. Note Payable to Shareholders

 

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Payable, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

 

Note 7. Stock Subscription Receivable

 

On November 26, 2019, the Company received $65,000 in advance related to the sale of 260,000 registered common shares to an accredited investor. While $65,000 was received on November 26, 2019, the agreement was not signed until December 2, 2019 and thus as of the end of the reporting period, November 30, 2019, the Company had not issued the 260,000 shares to the investors. The $65,000 was booked as a Stock Subscription Receivable. These underlying shares were issued during December of 2019 and will be reflected in the quarterly financial reporting period ending February 2020 and are listed herein in the Subsequent Events footnote.

 

 13 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

 

(Unaudited)

 

Note 8. Related Party

 

In October 2017 – August 31, 2018, the Company incurred a related party debt in the amount of $10,000 to an entity related to the legal custodian of the Company for professional fees. As of August 31, 2018, this balance was forgiven and was included as part of the $168,048 Cancellation of Debt Income on the Statement of Operations.

 

In November 30, 2017 – August 31, 2018, the Company issued a $35,554 in multiple notes payable to an entity related to the legal custodian of the Company. The notes payable bear interest at an annual rate of 10% and is convertible to common shares of the Company at $0.0001 per share. On May 8, 2018, $13,000 of the principal balance on notes payable were converted to common stock. The remaining principal balance was forgiven and included as Cancellation of Debt Income on the Income Statement for the year ended August 31, 2019.

 

In March 2018 and May 2018, a legal custodian of the Company funded the Company $600 in advances. On August 31, 2018, this amount was reclassified as a note payable, that bears interest at an annual rate of 10% and is payable upon demand.

 

In connection with the above notes, the Company recognized a beneficial conversion feature of $27,954, representing the intrinsic value of the conversion features at the time of issuance. This beneficial conversion feature was accreted to interest expense during the year ended August 31, 2018.

 

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen for loans made to the Company, each in the amount of $16,666,67 for a total balance of $33,334. The notes bear interest at 5% per annum and do not have a fixed payment schedule or maturity date. These notes are additionally described herein in Footnote 6 - Notes Payable.

 

On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

 

During the quarterly financial period ending November 30, 2019, the Company recorded $5,000 in consulting revenue associated with a Related Party, Edward Manolos. Mr. Manolos is a Related Party by way of his position as a director of the Company and due to his partial ownership of the contracted consulting organization to which services have been offered.

 

 

 14 
 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

 

Note 9. Income Taxes

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets at August 31, 2019 and November 30, 2019, are as follows: 

 

   November 30, 2019  August 31,
2019
Deferred tax assets:          
Net operating loss carryforwards  $385,437   $212,618 
Capitalized research and development   -------    - 
Research and development credit carry forward   1,963    1,963 
Total deferred tax assets   387,400    214,581 
           
Less: valuation allowance   (387,400)   (214,581)
           
Net deferred tax asset  $   $ 

 

The net increase in the valuation allowance for deferred tax assets was $172,819 for the three months ended November 30, 2019. The Company evaluates its valuation allowance on an annual basis based on projected future operations. When circumstances change and this causes a change in management’s judgment about the realizability of deferred tax assets, the impact of the change on the valuation allowance is reflected in current operations.

 

For federal income tax purposes, the Company has net U.S. operating loss carry forwards at November 30, 2019 available to offset future federal taxable income, if any, of $1,127,601 which will fully expire by the fiscal year ended August 31, 2039.  Accordingly, there is no current tax expense for the three months ended November 30, 2019. In addition, the Company has research and development tax credit carry forwards of $1,923 at November 30, 2019, which are available to offset federal income taxes and fully expire by November 30, 2039.

 

The utilization of the tax net operating loss carry forwards may be limited due to ownership changes that have occurred as a result of sales of common stock.

 

The effects of state income taxes were insignificant for the three months ended November 30, 2019 and November 30, 2018.

 

 

 Note 10 – Convertible Note Payable

 

On November 6, 2019, the Company issued a convertible promissory note in the principal amount of $20,000 along with 26,667 three-year warrants exercisable at $3.50 per share in exchange for proceeds of $20,000. The note matures May 6, 2020 and bears interest at the rate of 7% per annum, payable at maturity. Commencing thirty (30) days following the issuance date, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a conversion price equal to the lower of (i) $0.75 per share; or (ii) 80% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the issuance of the warrants as well as the beneficial conversion feature, upon issuance, the Company recognized total debt discount of $20,000, which is being amortized to interest expense over the term of the note. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As of November 30, 2019, the carrying value of the note was $2,637, net of debt discount of $17,363.

 

 

 15 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

 

 

NOTE 11 – DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

 

Upon the issuance of certain convertible notes payable, the Company determined that the features associated with the embedded conversion option embedded in the notes payable should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions.

 

At the issuance date of the convertible note payable, the Company estimated the fair value of the embedded derivatives of $28,521 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 398.53%, (3) weighted average risk-free interest rate of 1.60%, (4) expected life of three years and (5) estimated fair value of the Company’s common stock of $1.07 per share.

 

On November 30, 2019, the Company estimated the fair value of the embedded derivative of $16,018 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 394.12%, (3) weighted average risk-free interest rate of 1.61%, (4) expected life of 2.94 years, and (5) estimated fair value of the Company’s common stock of $0.55 per share.

 

The Company adopted the provisions of ASC 825-10, Financial Instruments (“ASC 825-10”). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

 

 

 16 
 

 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

 ●Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;

 

Level 2 — Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and

 

Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.

 

All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

 

The Company recognizes its derivative liabilities as Level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company.

 

As of November 30, 2019, the Company did not have any derivative instruments that were designated as hedges.

 

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of November 30, 2019 and August 31, 2019:

 

   November 30,
2019
  Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
Derivative liability  $16,018   $-   $-   $16,018 
                     

 

    August 31,
2019
    Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
Derivative liability   $         -     $         -     $         -     $         -  
                                 

 

 17 
 

 

MCTC HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

November 30, 2019

(Unaudited)

 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the three months ended November 30, 2019:

Balance, August 31, 2019  $- 
Transfers in due to issuance of convertible promissory notes   28,521 
Transfers out due to conversions of convertible promissory notes   - 
Mark to market to November 30, 2019   (12,503)
Balance, November 30, 2019  $16,018 
Gain on change in derivative liability for the three months ended November 30, 2019  $12,503 

 

Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company’s balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.

Note 12. Subsequent Events

On December 30, 2019, The Company sold a convertible note to an accredited investor. The $63,000 note calls for annualized interest of 10% and is due on December 20, 2020. The note converts in common shares at 40% discount. This note is attached as an exhibit hereto.

On December 16, 2019, the Company’s board of directors by unanimous written consent caused the authorization of ten million (10,000,000) shares of preferred stock, par value $0.0001 per share, of the Company ("Preferred Stock") in one or more series, and expressly authorized the Board of Directors of the Company (the "Board"), subject to limitations prescribed by law, to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock, and, with respect to each such series, to establish and fix the number of shares to be included in any series of Preferred Stock and the designation, rights, preferences, powers, restrictions, and limitations of the shares of such series.

 Additionally, the Board of Directors authorized the designation of eight million (8,000,000) preferred shares as “Series A Preferred Stock” and resolved to issue the Series A Preferred Stock to the directors of the corporation pro rata. The Series A Preferred Stock is not convertible into any other form of Securities, including common shares, of the Company. Holders of Series A Preferred Stock shall be entitled to fifty (50) votes for every Share of Series A Preferred Stock beneficially owned as of the record date for any shareholder vote or written consent. A copy of the Certificate of Designation is attached as an exhibit hereto.

 

On December 2, 2019, the Company signed an agreement to sell 260,000 registered common shares to an accredited investor. On November 26, 2019, the Company received $65,000 in advance of the signing agreement. The $65,000 was booked as a Stock Subscription Receivable. The underlying shares were issued during December of 2019 and will be reflected in the quarterly financial reporting period ending February 2020. See Note 7 to Financial Statements. The stock purchase agreement is attached hereto.

 

 18 
 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

Except for the historical information presented in this document, the matters discussed in this Form 10-Q for the quarter ended November 30, 2019, contain forward-looking statements which involve assumptions and our future plans, strategies, and expectations. These statements are generally identified by the use of words such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

 

Such forward-looking statements include statements regarding, among other things, (a) our potential profitability and cash flows, (b) our growth strategies, (c) our future financing plans, and (d) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.

 

Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

 

Except where the context otherwise requires and for purposes of this Form 10-Q only, “we,” “us,” “our,” “Company,” “our Company,” and “MCTC” refer to “MCTC Holdings, Inc.”.

 

Overview

 

The following discussion and analysis of our financial condition and results of operations (“MD&A”) should be read in conjunction with our financial statements and the accompanying notes to the financial statements included in this Form 10-Q.

 

The MD&A is based on our financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses and related disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions .

 

Description of Business

 

Our principal executive office is located at 520 S Grand Avenue, Suite 320, Los Angeles, California 90071. Our telephone number is (310) 986-4929 and our website is accessible at www.cannabisglobalinc.com. Unless expressly noted, none of the information on our website is part of this filing or any filing supplement.

 19 
 

 

Our shares of Common Stock are quoted on the OTC Markets Pink, operated by OTC Markets Group, Inc. As of the filing date, the Company’s shares trade under the symbol MCTC. On September 30, 2019 there was a one for 15 stock split.

 

We are a fully operational research and development company focused on cannabinoid research.

 

Our aim is to create and commercialize engineered technologies to deliver hemp extracts and cannabinoids to the human body. Additionally, we plan to develop consumer products, based on these and other technologies.

Our R&D programs included the following;

  1) Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.

 

  2) Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.

 

  3) Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.

 

  4) Establishment of new methods to increase the bioavailability of cannabinoids to the human body through utilization of proven bioenhancers, including d-α-Tocopherol polyethylene glycol 1000 succinate (TPGS), which is widely used as a water-soluble vitamin E formulation.

 

  5) Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.

 

It is the Company’s strategy to develop a growing portfolio of intellectual property relating to the processing of hemp extracts and cannabinoids into forms that are easily and efficiently delivered to the human body and to companion animals.

 

To achieve this goal, our research and development efforts are primarily focused on these areas: 1) polymeric cannabinoid nanoparticles, 2) polymeric cannabinoid nanofibers, 3) devices for the delivery of cannabinoids and other active ingredients and 4) unique formulations of hemp extracts and cannabinoids utilizing d-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS), a water soluble form of vitamin E, for oral and dermal delivery. The Company plans to continue such research efforts in order to develop technologies, methods of manufacturing and products that are novel and to possibly protect such technologies, methods of manufacturing and products via U.S. and international patents and trademarks, and other forms of intellectual property protection.

The Company has begun to file for intellectual property protection for several of its developed technologies and products.

These include:

● Provisional Patent Filing - Sub-micron and micro-sized particles combining cannabinoids and d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) produced via an electrosprayed apparatus.

 

● Provisional Patent Filing - Edible cannabinoid delivery and packaging technology enhanced with solid polymeric nanoparticles and d-α-tocopheryl polyethylene glycol 1000 (TPGS) succinate containing nanoparticles produced via an electrosprayed apparatus.

 

 20 
 

 

 

● Provisional Patent Filing - Edible, 4D printed thermal, moisture or environmental induced shape-changing device for delivery of cannabinoids or other active ingredients to beverages or foods.

 

● Provision Patent - Nanoparticles and nanofibers of cannabinoids.

 

● Provision Patent Filing - Powdered formations of cannabinoids.

 

● Trade Mark – Hemp You Can Feel™

 

● Trade Mark – Gummies You Can Feel™

 

Employees

 

As of November 30, 2019, we had one employee, who is our CEO. The Company relies on the services of contractors and service providers who perform various operational and financial related services for the organization.

 

Results of Operations

 

For the Three months Ended November 30, 2019 and November 30, 2018

 

The Company began recognizing revenues from business operations during the quarterly financial period ending November 30, 2019. Product revenues for the quarterly financial period ending November 30, 2019, were $5,003 compared to zero reported during the quarterly financial period ending November 30, 2018. The increase was attributable to the Company receiving orders from a new customer. Consulting Revenues for the quarterly financial period ending November 30, 2019, were $5,000, which was associated with a Related Party, Edward Manolos. Mr. Manolos is a Related Party by way of his position as a director of the Company and due to his partial ownership of the contracted consulting organization to which services have been offered.

 

Total Revenues for the quarterly financial period ending November 30, 2019, were $10,003 compared to zero revenues for the year earlier period. The increase was a result of a customer order and a Related Party consulting contract.

 

During the financial period ending November 30, 2019, cost of goods sold was $2,900 compared to zero for the years earlier period. The increase was attributable to the Company receiving orders from new customers.

 

Accounts receivable rose to $10,003 for the period ending November 30, 2019, as a result of the Company signing an initial order for products and due to an increase in consulting revenues. Of this $10,003 accounts receivable, $5,000 is a Related Party transaction. During the quarterly financial period ending November 30, 2019, the Company book $5,000 in consulting revenue associated with a Related Party, Edward Manolos. Mr. Manolos is a Related Party by way of his position as a director of the Company and due to his partial ownership of the contracted consulting organization to which services have been offered.

 

During the financial period ending November 30, 2019, the Company began to incur operating expense as it organized the production of new products. Advertising expense during the period was $1,423 and consulting services were $35,883. Professional fees and General and Administrative Fees were $148,955 and $187,521, respectively. Total operating expenses were $373,793. For the period ending November 30, 2018, the Company incurred only $17,283 in operating expenses. The increase in operating expenses for the period ending 2019 versus 2018 was attributable to the reorganization of the business, the hiring of consultants and preparation to accept customer orders for new products developed.

 

Interest expenses for the financial period ending November 30, 2019 were $31,250 compared to $2,522 for the financial period ending November 30, 2018. The decrease was attributable to notes sold during the 2019.

 

 

 21 
 

 

 

During the financial period ending November 30, 2019, net loss was $385,437 compared to $17,283 for the financial period ending November 30, 2018. The increase in net loss was attributable mainly to increased spending associated with the reorganization of the business, expenses relating to hiring consultants and general costs associated with the design of new product in preparation of customer orders. The net loss financial period ending November 30, 2019, results in a loss per share of $0.02, compared to a negligible loss per share ($0.00) during the year ago period.

 

Liquidity and Capital Resources

 

As of the end of the quarterly financial period ending November 30, 2019, we had an accumulated deficit of $1,513,038 and cash and cash equivalents of $64,702.

 

In January 2014, we received funding by issuing a $70,000 note payable to a shareholder. The $70,000 note payable was due on January 9, 2016 and has not been repaid as of the date of this filing and is thus in default as of May 31, 2019. As of May 31, 2019, $70,000 remained outstanding.

 

Our primary internal sources of liquidity were provided by proceeds from the sale of unregistered common shares and warrants of the Company as follows:

 

On July 3, 2019, we sold 2,000,000 restricted shares at $0.025 a share for the amount of $50,000 to an accredited investor. The investor also received 2,000,000 warrants to purchase 2,000,000 shares at a price of $0.15 per share. The warrants expire on July 3, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

 

On July 10, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on July 10, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

 

On July 16, 2019, we sold 1,400,000 restricted shares at $0.025 a share for the amount of $35,000 to an accredited investor. The investor also received 1,400,000 warrants to purchase 1,400,000 shares at a price of $0.15 per share. The warrants expire on July 16, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings. As of the date of this filing, these shares have not yet been issued to the purchaser.

 

On July 19, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on July 19, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings.

 

On August 15, 2019, we sold 2,000,000 restricted shares at $0.025 a share for the amount of $50,000 to an accredited investor. The investor also received 2,000,000 warrants to purchase 2,000,000 shares at a price of $0.15 per share. The warrants expire on August 15, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings. As of the date of this filing, these shares have not yet been issued to the purchaser.

 

 22 
 

 

 

On August 19, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on August 19, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings. As of the date of this filing, these shares have not yet been issued to the purchaser.

 

On August 27, 2019, we sold 1,000,000 restricted shares at $0.025 a share for the amount of $25,000 to an accredited investor. The investor also received 1,000,000 warrants to purchase 1,000,000 shares at a price of $0.15 per share. The warrants expire on August 27, 2020. The sale was made pursuant to SEC Rule 506 Section 4(2), which provides exemption from registration for transactions, which are not public offerings. As of the date of this filing, these shares have not yet been issued to the purchaser.

 

On August 26, 2019, we filed Form S-1 registration for the resale of up to 13,156,667 shares from certain selling holders and for the sale 20,000,000 newly issued common stock as part of a primary offering from the Company. These shares amounts are indicated based on pre-split basis not taking into account the 1 for 15 stock split occurring on August 30, 2019. On a post-split basis these share amounts are adjusted to 877,112 for sales from certain selling shareholders and 1,333,333 newly issued common stock as part of a primary offering from the Company. The S-1 registration was declared effective by the Commission on September 16, 2019.

 

On November 6, 2019, we sold a convertible not to an accredited investor for $20,000. The terms of the six month note allow 7% annual interest and for the conversion into common shares at $0.75. Additionally, the investor received a warrant providing the investor the right to purchase 26,666 common shares at a price of $3.50.

 

On November 11, 2019, we sold 83,333 common shares registered in the direct offering under its From S-1 made effective by the SEC on September 16, 2019, to an accredited investor in exchange for $25,000.

 

On November 25, 2019, we sold 120,000 common shares registered in the direct offering under its From S-1 made effective by the SEC on September 16, 2019, to an accredited investor in exchange for $50,000.

 

We plan to use the proceeds from sales of the primary offering to partially finance our business operations. We also intend to utilize cash on hand, loans and other forms of financing such as the sale of additional equity and debt securities and other credit facilities to conduct our ongoing business, and to also conduct strategic business development and implementation of our business plans generally. We are not intending to use any off-balance sheet financing arrangements.

 

Other Contractual Obligations

 

Our Company entered into a one year during August of 2019 for a commercial food production facility located in Los Angeles, California. The one-year lease at a base rate of $3,600 per month through September of 2020.

 

 

 

 23 
 

 

 

Off-Balance Sheet Arrangements

 

 We have no off-balance sheet arrangements. 

Recently Issued Accounting Pronouncements

 

We review new accounting standards as issued. Although some of these accounting standards issued or effective after the end of our previous fiscal year may be applicable to the Company, we have not identified any standards that we believe merit further discussion. We do not expect the adoption of any recently issued accounting pronouncements to have a significant impact on our financial position, results of operations, or cash flows. 

Item 3. Quantitative & Qualitative Disclosures About Market Risk

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Management is responsible for establishing and maintaining adequate disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in its Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely and reliable financial reporting and the preparation of financial statements in accordance with accounting principles generally accepted in the United States of America.

 

As of the quarter ended November 30, 2019, our principal executive officer and principal financial officer completed an assessment of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e), to determine the existence of any material weaknesses or significant deficiencies under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the registrant's financial reporting.

 

Based on that evaluation, we concluded that our disclosure controls and procedures over financial reporting were not effective as of November 30, 2019.

 

Changes in Internal Controls over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the quarter ended November 30, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

 24 
 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On November 22, 2019, the Company filed suit against Jeet Sidhru and Jatinder Bhogal in the District Court of Clark County Nevada, Case number A-19-805943-C. Mr. Sidhru and Mr. Bhogal were formerly directors and officers of the Company. The Company’s complaint alleges that Mr. Sidhru and Mr. Bhogal breached their fiduciary duties to the Company, including their fiduciary duties of due care, good faith and loyalty, by recklessly and intentionally failing to maintain the Company’s statutory corporate filings with the State of Nevada, OTC Markets and the U.S. Securities and Exchange Commission, and abandoning the Company and its shareholders. The Company’s complaint also alleges that Mr. Sidhru and Mr. Bhogal engaged in conflicted transactions involving the Company, in which each were unjustly enriched. The Company served Mr. Bhogal, and received notice of representation of both defendants. The case is currently in its early phase, as neither defendant has answered the complaint.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On November 6, 2019, we sold a convertible note to an accredited investor for $20,000. The terms of the six month note allow 7% annual interest and for the conversion into common shares at $0.75. Additionally, the investor received a warrant providing the investor the right to purchase 26,666 common shares at a price of $3.50.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

   
   
Exhibit No. Description of Exhibit
   
2.1 Convertible Note Agreement Dated November 6, 2019(1)
   
2.2 Stock Purchase Agreement Dated November 11, 2019(1)
   
2.3 Stock Purchase Agreement November 25, 2019(1)
   
3.1 Certificates of Designation – Series A Preferred Stock(1)
   
3.2 Board of Directors Resolution – Series A Preferred Stock Designation and Issuance(1)
   
31.1 * Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13(a)-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1 *  Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 USC. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
        

 

  *Filed herewith.

 

(1)    Incorporated by reference to the exhibits filed as part of the report on Form 10-K filed by MCTC Holdings, Inc. on November 29, 2018.

 

 

 25 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  

 

  MCTC Holdings, Inc.
  (Registrant)
     
By: /s/ Arman Tabatabaei
January 14, 2020 Arman Tabatabaei
  President, Chief Executive Officer,
 

Chief Financial Officer, and Director

 

 

 

 

 

 

 

 

 26 
 

 

 

 

EX-31.1 2 ex31_1.htm CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Arman Tabatabaei, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q for the quarter ending November 30, 2019, of MCTC Holdings, Inc. (the “registrant”);

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. As the registrant’s certifying officer I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

  5. As the registrant's certifying officer I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date:  January 14, 2020 /s/ Arman Tabatabaei
  Arman Tabatabaei
  Chief Executive Officer and Chief Financial Officer

 

 

 

 

 

 

EX-32 3 ex32_1.htm

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of MCTC Holdings, Inc. (the “ Company”) on Form 10-Q for the quarter ending November 30, 2019, as filed with the Securities and Exchange Commission on January 14, 2020, (the “Report”), I, Arman Tabatabaei, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   

 

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         

   

Date:  January 14, 2020 /s/ Arman Tabatabaei
  Arman Tabatabaei
  Chief Executive Officer and Chief Financial Officer

 

 

 

 

EX-101.SCH 4 mctc-20191130.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern Uncertainties link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Net Loss Per Share link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Notes Receivable - Related Party link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Note Payable to Shareholder link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Stock Subscription Receivable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Related Party link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Convertible Note Payable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Derivative Liability and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Derivative Liability and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Organization and Description of Business (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Going Concern Uncertainties (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Net Loss Per Share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Notes Receivable - Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Note Payable to Shareholder (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Stock Subscription Receivable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Related Party (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Convertible Note Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Derivative Liability and Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Derivative Liability and Fair Value Measurements (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Derivative Liability and Fair Value Measurements (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 mctc-20191130_cal.xml XBRL CALCULATION FILE EX-101.INS 6 mctc-20191130.xml XBRL INSTANCE FILE 0001413488 2018-08-31 0001413488 2019-11-30 0001413488 2019-09-01 2019-11-30 0001413488 2018-09-01 2018-11-30 0001413488 2019-08-31 0001413488 2018-11-30 0001413488 2020-01-14 0001413488 2007-08-22 0001413488 2007-09-25 0001413488 2007-09-01 2007-09-25 0001413488 2019-05-01 2019-05-25 0001413488 MCTC:SplitTeeMember 2019-07-09 0001413488 MCTC:SplitTeeMember 2019-08-23 0001413488 MCTC:SplitTeeMember 2019-07-08 2019-07-09 0001413488 MCTC:EdwardManolosMember 2019-05-25 0001413488 MCTC:DanNguyenMember 2019-05-25 0001413488 2019-11-26 0001413488 2019-11-01 2019-11-26 0001413488 MCTC:LegalCustodianMember 2018-08-31 0001413488 MCTC:LegalCustodianOneMember 2018-08-31 0001413488 MCTC:LegalCustodianOneMember 2018-05-01 2018-05-08 0001413488 MCTC:LegalCustodianTwoMember 2018-03-01 2018-05-31 0001413488 MCTC:LegalCustodianTwoMember 2018-08-31 0001413488 MCTC:LegalCustodianOneMember 2017-11-30 2018-08-31 0001413488 MCTC:ConvertiblePromissoryNoteMember 2019-11-01 2019-11-06 0001413488 MCTC:ConvertiblePromissoryNoteMember 2019-11-06 0001413488 MCTC:ConvertiblePromissoryNoteMember 2019-09-01 2019-11-30 0001413488 MCTC:ConvertiblePromissoryNoteMember 2019-11-30 0001413488 us-gaap:FairValueInputsLevel1Member 2019-11-30 0001413488 us-gaap:FairValueInputsLevel2Member 2019-11-30 0001413488 us-gaap:FairValueInputsLevel3Member 2019-11-30 0001413488 us-gaap:FairValueInputsLevel1Member 2019-08-31 0001413488 us-gaap:FairValueInputsLevel2Member 2019-08-31 0001413488 us-gaap:FairValueInputsLevel3Member 2019-08-31 0001413488 us-gaap:SubsequentEventMember us-gaap:SeriesAPreferredStockMember 2019-12-02 0001413488 us-gaap:SubsequentEventMember 2019-12-16 0001413488 us-gaap:SubsequentEventMember MCTC:AccreditedInvestorMember 2019-12-30 0001413488 us-gaap:SubsequentEventMember MCTC:AccreditedInvestorMember 2019-12-01 2019-12-30 0001413488 us-gaap:SubsequentEventMember us-gaap:SeriesAPreferredStockMember 2019-12-16 0001413488 MCTC:ClassAPreferredStockMember 2018-09-01 2018-11-30 0001413488 MCTC:ClassAPreferredStockMember 2018-12-01 2019-11-30 0001413488 MCTC:ClassAPreferredStockMember 2018-08-31 0001413488 MCTC:ClassAPreferredStockMember 2018-11-30 0001413488 MCTC:ClassAPreferredStockMember 2019-11-30 0001413488 us-gaap:CommonStockMember 2018-09-01 2018-11-30 0001413488 us-gaap:CommonStockMember 2018-12-01 2019-11-30 0001413488 us-gaap:CommonStockMember 2018-08-31 0001413488 us-gaap:CommonStockMember 2018-11-30 0001413488 us-gaap:CommonStockMember 2019-11-30 0001413488 MCTC:CommonStockToBeIssuedMember 2018-09-01 2018-11-30 0001413488 MCTC:CommonStockToBeIssuedMember 2018-12-01 2019-11-30 0001413488 MCTC:CommonStockToBeIssuedMember 2018-08-31 0001413488 MCTC:CommonStockToBeIssuedMember 2018-11-30 0001413488 MCTC:CommonStockToBeIssuedMember 2019-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2018-09-01 2018-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2018-12-01 2019-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2018-08-31 0001413488 us-gaap:AdditionalPaidInCapitalMember 2018-11-30 0001413488 us-gaap:AdditionalPaidInCapitalMember 2019-11-30 0001413488 us-gaap:RetainedEarningsMember 2018-09-01 2018-11-30 0001413488 us-gaap:RetainedEarningsMember 2018-12-01 2019-11-30 0001413488 us-gaap:RetainedEarningsMember 2018-08-31 0001413488 us-gaap:RetainedEarningsMember 2018-11-30 0001413488 us-gaap:RetainedEarningsMember 2019-11-30 0001413488 2018-12-01 2019-11-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure 15093128 0.001 0.001 0.0001 290000000 290000000 300000000000000 0.0001 0.0001 0.0001 10000000 10000000 10000000 8000000 MCTC Holdings, Inc. 0001413488 10-Q 2019-11-30 false --08-31 Non-accelerated Filer 2020 true true false Yes Q1 Yes 000-27039 DE 40000 40000 20000 20000 14000 14000 10000 35554 600 92 0 0 0 0 0 0 0 0 14833128 12713129 1000000 260000 260000 14833128 12713129 1000000 -385437 -17283 -17283 -385437 -385437 -1513038 -738004 -0.03 0.00 0 777 -92 -1745 0 500 <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Derivative Instruments</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b>Consolidation</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan &#38; Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Cash and Cash Equivalents</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><i>Inventory</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of November 30, 2019 and November 30, 2018, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Deposits</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see &#8220;Costs of Revenues&#8221; below). There were no deposits as of November 30, 2019 or November 30, 2018.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Prepaid Expenses and Other Current Assets</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors&#8217; services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Accounts Receivable</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of November 30, 2019 and November 30, 2018, we had $0 and $0 allowance for doubtful accounts, respectively.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Property and Equipment, net</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under &#8220;Accounting for the Impairment of Long-Lived Assets.&#8221;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Accounting for the Impairment of Long-Lived Assets</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. We have not recorded any impairment charges related to long-lived assets during the quarter ended November 30, 2019, and November 30, 2018.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Beneficial Conversion Feature</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (&#8220;BCF&#8221;). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ACF&#8221;) Topic 470-20 <i>Debt with Conversion and Other Options</i>. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Revenue Recognition</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) made effective ASU 2014-09 &#8220;Revenue from Contracts with Customers&#8221; to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Product Sales</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. Generally, we drop-ship orders to our clients with shipping-point or destination terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Costs of Revenues</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Income Taxes</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending November 30, 2018, and November 30, 2019, we incurred no income taxes and had no liabilities related to federal or state income taxes.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Loss Contingencies</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Net Income (Loss) Per Common Share</i></b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We report net income (loss) per common share in accordance with FASB ASC 260, &#8220;Earnings per Share&#8221;. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.</p> 538,646 for 1 Lauderdale Holdings, LLC, a Florida limited liabiblity company, in which former Chief Executive Officer, Garry McHenry maintains a controlling interest, sold 8,666,667 common shares of MCTC Holdings, Inc., representing approximately 70.7% of the 12,257,640 issued and outstanding shares to Messrs. Robert Hymers, Edward Manolos and Dan Nguyen, all of whom were previously unaffiliated parties. Each purchased 2,888,889 common shares for $108,333.33 each or an aggregate of $325,000, utilizing personal funds. This series of transactions constitute a change in control of the Company. The assets and liabilities of MicroChannel Corp. were spun out to Lauderdale Holdings, LLC as part of the change in control. 0 0 0 0 0 0 0 0 0 0 0.10 5000 1666667 1666667 0.05 0.05 65000 600 65000 0.10 0.10 168048 0.0001 13000 27954 5000 269532 212618 0 0 1963 1963 271495 214581 271495 214581 0 0 56914 1127601 2039-08-31 0 0 20000 26667 3.50 20000 2020-05-06 0.07 0.10 20000 2637 17363 28521 16018 0.00 0.00 3.9853 3.9412 0.0160 0.0161 P3Y P2Y11M8D 1.07 0.55 16018 0 0 0 16018 0 0 0 28521 0 -12503 63000 2020-12-20 12503 -182380 -15331 -5885 0 104829 -1070 10003 0 -12503 0 116553 0 698 0 31158 0 -6250 0 0 0 4652 64702 152082 4677 -87380 25 95000 15356 0 15356 20000 0 75000 0 0 0 0 0 15632 0 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1. Organization and Description of Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">MCTC Holdings, Inc. is located at 520 S Grand Avenue, Suite 320, Los Angeles, California 90071. Our telephone number is (310) 986-4929 and our website is accessible at www.cannabisglobalinc.com. Our shares of Common Stock are quoted on the OTC Markets Pink, operated by OTC Markets Group, Inc., under the ticker symbol &#8220;MCTC.&#8221; We are a research and development company focused on cannabinoid research.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Our aim is to create and commercialize proprietary engineered technologies to deliver hemp extracts and cannabinoids to the human body. Additionally, we plan to develop consumer products, based on these and other proprietary technologies.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Our R&#38;D programs included the following;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 9%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 4%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">1)</font></td> <td style="width: 87%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.</font></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 56pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 9%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 4%; font: 11pt Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">2)</font></td> <td style="width: 87%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 9%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 4%; font: 11pt Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">3)</font></td> <td style="width: 87%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 9%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 4%; font: 11pt Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">4)</font></td> <td style="width: 87%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Establishment of new methods to increase the bioavailability of cannabinoids to the human body through utilization of proven bioenhancers, including d-&#945;-Tocopherol polyethylene glycol 1000 succinate (TPGS), which is widely used as a water-soluble vitamin E formulation.</font></td></tr> </table> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 9%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 12pt Times New Roman, Times, Serif">&#160;</font></td> <td style="width: 4%; font: 11pt Calibri, Helvetica, Sans-Serif"><font style="font: 10pt Times New Roman, Times, Serif">5)</font></td> <td style="width: 87%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.</font></td></tr> </table> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On August 9, 2019, our board of directors determined the Company no longer meets the definition of a Shell Company as defined in Item 1101(b) of Regulation AB ( &#167; 229.1101(b) of this chapter), which defines a Shell Company as one that has: 1) No or nominal operations; and 2) Either: (i) No or nominal assets; (ii) Assets consisting solely of cash and cash equivalents; or (iii) Assets consisting of any amounts of cash and cash equivalents and nominal other assets. By way of the Company: 1) beginning business activities and operations, 2) hiring its CEO, 3) appointing a highly experienced board of directors, 4) retaining consultants, 5) signing two property leases, 6) approval of budgets and business plans for several initiatives, 7) production of product samples, 8) sales initiatives to prospective customers, and other related business activities, the board of directors believes such activities are qualified as non-nominal operations and therefore the board of directors declared its believe the Company is no longer defined by Item 1101(b) of Regulation AB ( &#167; 229.1101(b) of this chapter).</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On August 9, 2019, the Company filed a DBA in California registering the operating name Cannabis Global. On July 1, 2019, the Company acquired Action Nutraceuticals, Inc., a company owned by our current CEO, Arman Tabatabaei. The transaction value was nominal, at only One Thousand Dollars ($1,000). Therefore, the Company believes its acquisition of Action Nutraceuticals, Inc. is not an acquisition of a significant amount of assets, or a transaction defined by 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, that would require specific disclosures under the section cited. Regardless, the Company will disclose the transaction pursuant to 17 CFR &#167; 229.404 - (Item 404) &#8220;Transactions with Related Persons, Promoters and Certain Control Persons.&#8221; No intellectual property, patents or trademarks were acquired in the transaction.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On July 1, 2019, the Company entered into a 100% business acquisition with Action Nutraceuticals, Inc., a company owned by our CEO, Arman Tabatabaei. The value of the transaction value was nominal, at only One Thousand Dollars ($1,000) thus, the Company believes the business acquisition of Action Nutraceuticals, Inc. is transaction NOT defined by 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons that would require specific disclosure under the section cited. Regardless, of the requirements of 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, the Company makes this disclosure.<b>&#160;</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On or about June 27, 2018 we changed domiciles from the State of Nevada to the State of Delaware and thereafter reorganized under the Delaware Holding Company Statute Delaware General Corporation Law Section 251(g). On or about July 12, 2018, two subsidiaries were formed for the purpose of effecting the reorganization. We incorporated MCTC Holdings, Inc. and MCTC Holdings Inc. incorporated MicroChannel Corp. We then effected a merger involving the three constituents and under the terms of the merger we were merged into MicroChannel Corp., with MicroChannel Corp. surviving and our separate corporate existence ceasing. Following the merger MCTC Holdings, Inc. became the surviving publicly traded issuer and all of our assets and liabilities were merged into MCTC Holdings, Inc.&#8217;s wholly owned subsidiary MicroChannel Corp. Our shareholders became the shareholders of MCTC Holdings, Inc. on a one for one basis.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On May 25, 2019, Lauderdale Holdings, LLC, a Florida limited liability company, in which former Chief Executive Officer, Garry McHenry maintains a controlling interest, sold 8,666,667 common shares of MCTC Holdings, Inc., representing approximately 70.7% of the 12,257,640 issued and outstanding shares to Messrs. Robert Hymers, Edward Manolos and Dan Nguyen, all of whom were previously unaffiliated parties. Each purchased 2,888,889 common shares for $108,333.33 each or an aggregate of $325,000, utilizing personal funds. This series of transactions constitute a change in control of the Company. The assets and liabilities of MicroChannel Corp. were spun out to Lauderdale Holdings, LLC as part of the change in control.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On January 14, 2009, Octillion Corp. (Symbol: OCTL), the parent company of MicroChannel announced that it had changed its name to New Energy Technologies, Inc. (Symbol: NENE) (&#8220;New Energy&#8221;). The name change became effective on the Over-the-Counter Bulletin Board at the opening of trading on January 14, 2009. On June 24, 2008, MicroChannel announced that it initiated trading of its stocks on the OTC Bulletin Board under the stock symbol &#8220;MCTC&#8221;. On August 22, 2007, by corporate action taken by MicroChannel&#8217;s executive team and board members, the company amended its Articles of Incorporation to increase its authorized capital stock to 300,000,000 million shares of common stock, $0.0001 par value per share. As of September 25, 2007, there were 1,000,000 shares of common stock were issued and outstanding; there were no preferred shares issued and outstanding. The directors and sole shareholder have approved a forward split of their issued and outstanding shares of common stock on the basis of 538,646 for 1 for the purpose of effecting the distribution.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On April 4, 2005, MultiChannel changed its name to MicroChannel Technologies Corporation. The Company&#8217;s original name was MultiChannel Technologies Corporation (&#8220;MultiChannel&#8221;) which was incorporated on February 28, 2005 under the laws of the State of Nevada (U.S.A.) and was originally formed as a wholly-owned subsidiary of Octillion Corp. (&#8220;Octillion&#8221;). Octillion (a Canadian company was trading in the OTC Markets under the symbol &#8220;OCTL&#8221;). At the time of Octillion&#8217;s existence, Octillion was a development stage technology company focused on the identificati0n, acquisition and development of emerging solar energy and solar related technologies and products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2. Going Concern Uncertainties</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">During recent financial reporting periods, the Company began reporting revenue and has been active in reorganizing its business operations, these revenues being generated are nominal. The Company has an accumulated deficit of $1,513,038 as of November 30, 2019, and does not have positive cash flows from operating activities. The Company expects to incur additional losses as it executes its business strategy in the cannabinoid marketplace. The Company will be subject to the risks, uncertainties, and difficulties frequently encountered by early-stage companies. The Company may not be able to successfully address any or all of these risks and uncertainties. Failure to adequately do so could cause the Company&#8217;s business, results of operations, and financial condition to suffer. These conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern for a period of one year from the issuance date of these financial statements.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">The Company&#8217;s ability to continue as a going concern is an issue due to its net losses and negative cash flows from operations, and its need for additional financing to fund future operations. Management plans to obtain necessary funding from outside sources and through the sales of Company shares. There can be no assurance that such funds, if available, can be obtained on terms reasonable to the Company. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that may result from the outcome of this uncertainty.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">Based on the Company&#8217;s current level of expenditures, management believes that cash on hand is not adequate to fund operations for the next twelve months. Management of the Company is estimating approximately $1,000,000 will be required over the next twelve months to fully execute its business strategy. These can be no assurance the Company will be able to obtain such funds.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3. &#160;Summary of Significant Accounting Policies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties, and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies described below have the most significant impact on our consolidated financial statements. </p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Derivative Instruments&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Consolidation</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan &#38; Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Cash and Cash Equivalents</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Inventory</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of November 30, 2019 and November 30, 2018, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><b>&#160;</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Deposits</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see &#8220;Costs of Revenues&#8221; below). There were no deposits as of November 30, 2019 or November 30, 2018.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Prepaid Expenses and Other Current Assets</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors&#8217; services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Accounts Receivable</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of November 30, 2019 and November 30, 2018, we had $0 and $0 allowance for doubtful accounts, respectively.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Property and Equipment, net</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under &#8220;Accounting for the Impairment of Long-Lived Assets.&#8221;</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Accounting for the Impairment of Long-Lived Assets</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. We have not recorded any impairment charges related to long-lived assets during the quarter ended November 30, 2019, and November 30, 2018.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Beneficial Conversion Feature</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (&#8220;BCF&#8221;). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ACF&#8221;) Topic 470-20 <i>Debt with Conversion and Other Options</i>. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Revenue Recognition</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (&#8220;FASB&#8221;) made effective ASU 2014-09 &#8220;Revenue from Contracts with Customers&#8221; to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Product Sales</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. Generally, we drop-ship orders to our clients with shipping-point or destination terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Costs of Revenues</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-Based Compensation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. We had no stock-based compensation during the year ended November 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Income Taxes </i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending November 30, 2018, and November 30, 2019, we incurred no income taxes and had no liabilities related to federal or state income taxes.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Loss Contingencies</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Net Income (Loss) Per Common Share</i></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i></i>We report net income (loss) per common share in accordance with FASB ASC 260, &#8220;Earnings per Share&#8221;. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4. Net Loss Per Share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the financial reporting period ending November 30, 2019, the Company recorded a net loss of $385,437, which equals a loss of $0.03 on both a basic and fully diluted basis, per common share.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5. Notes Receivable &#8211; Related Party</b></p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Receivable, Related Party and in the footnote outlining Related Party Transactions. These notes are additionally described herein in Footnote 6- Notes to Shareholders, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos&#8217; and Mr. Nguyen&#8217;s associations as directors, the Company believes these transactions are defined by 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (&#8220;Split Tee&#8221;), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos&#8217; association as a director, the Company believes these transactions are defined by 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6. Note Payable to Shareholders</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Payable, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos&#8217; and Mr. Nguyen&#8217;s associations as directors, the Company believes these transactions are defined by 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 7. Stock Subscription Receivable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 26, 2019, the Company received $65,000 in advance related to the sale of 260,000 registered common shares to an accredited investor. While $65,000 was received on November 26, 2019, the agreement was not signed until December 2, 2019 and thus as of the end of the reporting period, November 30, 2019, the Company had not issued the 260,000 shares to the investors. The $65,000 was booked as a Stock Subscription Receivable. These underlying shares were issued during December of 2019 and will be reflected in the quarterly financial reporting period ending February 2020 and are listed herein in the Subsequent Events footnote.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 8. Related Party </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2017 &#8211; August 31, 2018, the Company incurred a related party debt in the amount of $10,000 to an entity related to the legal custodian of the Company for professional fees. As of August 31, 2018, this balance was forgiven and was included as part of the $168,048 Cancellation of Debt Income on the Statement of Operations.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 30, 2017 &#8211; August 31, 2018, the Company issued a $35,554 in multiple notes payable to an entity related to the legal custodian of the Company. The notes payable bear interest at an annual rate of 10% and is convertible to common shares of the Company at $0.0001 per share. On May 8, 2018, $13,000 of the principal balance on notes payable were converted to common stock. The remaining principal balance was forgiven and included as Cancellation of Debt Income on the Income Statement for the year ended August 31, 2019.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2018 and May 2018, a legal custodian of the Company funded the Company $600 in advances. On August 31, 2018, this amount was reclassified as a note payable, that bears interest at an annual rate of 10% and is payable upon demand.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the above notes, the Company recognized a beneficial conversion feature of $27,954, representing the intrinsic value of the conversion features at the time of issuance. This beneficial conversion feature was accreted to interest expense during the year ended August 31, 2018.</p> <p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen for loans made to the Company, each in the amount of $16,666,67 for a total balance of $33,334. The notes bear interest at 5% per annum and do not have a fixed payment schedule or maturity date. These notes are additionally described herein in Footnote 6 - Notes Payable.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (&#8220;Split Tee&#8221;), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos&#8217; association as a director, the Company believes these transactions are defined by 17 CFR &#167; 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify">During the quarterly financial period ending November 30, 2019, the Company recorded $5,000 in consulting revenue associated with a Related Party, Edward Manolos. Mr. Manolos is a Related Party by way of his position as a director of the Company and due to his partial ownership of the contracted consulting organization to which services have been offered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 9. Income Taxes </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company&#8217;s deferred tax assets at August 31, 2019 and November 30, 2019, are as follows:&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">November 30, 2019</td><td>&#160;</td> <td colspan="3" style="text-align: center">August 31, <br />2019</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: left; padding-left: 9pt">Net operating loss carryforwards</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">385,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">212,618</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 9pt">Capitalized research and development</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-------</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 9pt">Research and development credit carry forward</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,963</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,963</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 27pt">Total deferred tax assets</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">387,400</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">214,581</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: valuation allowance</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(387,400</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(214,581</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 27pt">Net deferred tax asset</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net increase in the valuation allowance for deferred tax assets was $172,819 for the three months ended November 30, 2019. The Company evaluates its valuation allowance on an annual basis based on projected future operations. When circumstances change and this causes a change in management&#8217;s judgment about the realizability of deferred tax assets, the impact of the change on the valuation allowance is reflected in current operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For federal income tax purposes, the Company has net U.S. operating loss carry forwards at November 30, 2019 available to offset future federal taxable income, if any, of $1,127,601 which will fully expire by the fiscal year ended August 31, 2039.&#160; Accordingly, there is no current tax expense for the three months ended November 30, 2019. In addition, the Company has research and development tax credit carry forwards of $1,923 at November 30, 2019, which are available to offset federal income taxes and fully expire by November 30, 2039.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The utilization of the tax net operating loss carry forwards may be limited due to ownership changes that have occurred as a result of sales of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effects of state income taxes were insignificant for the three months ended November 30, 2019 and November 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"><b>Note 10 &#8211; Convertible Note Payable</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On November 6, 2019, the Company issued a convertible promissory note in the principal amount of $20,000 along with 26,667 three-year warrants exercisable at $3.50 per share in exchange for proceeds of $20,000. The note matures May 6, 2020&#160;and bears interest at the rate of 7% per annum, payable at maturity. Commencing thirty (30) days following the issuance date, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a conversion price equal to the lower of (i) $0.75 per share; or (ii) 80% of the average of the previous twenty (20) trading day closing prices of the Company&#8217;s common stock, subject to adjustment. As a result of the issuance of the warrants as well as the beneficial conversion feature, upon issuance, the Company recognized total debt discount of $20,000, which is being amortized to interest expense over the term of the note. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As of November 30, 2019, the carrying value of the note was $2,637, net of debt discount of $17,363.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt"><b>NOTE 11 &#8211; DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Upon the issuance of certain convertible notes payable, the Company determined that the features associated with the embedded conversion option embedded in the notes payable should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the issuance date of the convertible note payable, the Company estimated the fair value of the embedded derivatives of $28,521 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 398.53%, (3) weighted average risk-free interest rate of 1.60%, (4) expected life of three years and (5) estimated fair value of the Company&#8217;s common stock of $1.07 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 30,&#160;2019, the Company estimated the fair value of the embedded derivative of $16,018 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 394.12%, (3) weighted average risk-free interest rate of 1.61%, (4) expected life of 2.94 years, and (5) estimated fair value of the Company&#8217;s common stock of $0.55 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Company adopted the provisions of ASC 825-10, Financial Instruments (&#8220;ASC 825-10&#8221;). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">&#160;&#9679;</td><td>Level 1 &#8212; Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;&#9;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>Level 2 &#8212; Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and&#9;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">&#9679;</td><td>Level 3 &#8212; Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">The Company recognizes its derivative liabilities as Level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">As of November 30, 2019, the Company did not have any derivative instruments that were designated as hedges.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of November 30, 2019 and August 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">November&#160;30,<br /> 2019</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Quoted<br /> Prices<br /> in Active<br /> Markets for<br /> Identical<br /> Assets<br /> (Level 1)</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Significant<br /> Other<br /> Observable<br /> Inputs<br /> (Level 2)</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Significant<br /> Unobservable<br /> Inputs<br /> (Level 3)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Derivative liability</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">16,018</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">16,018</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>August&#160;31,<br /> 2019</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>Quoted<br /> Prices<br /> in Active<br /> Markets for<br /> Identical<br /> Assets<br /> (Level 1)</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>Significant<br /> Other<br /> Observable<br /> Inputs<br /> (Level 2)</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>Significant<br /> Unobservable<br /> Inputs<br /> (Level 3)</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 31%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">Derivative liability</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 12%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 9%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; color: white"></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The following table provides a summary of changes in fair value of the Company&#8217;s Level 3 financial liabilities for the three months ended November 30, 2019:</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 85%">Balance, August 31, 2019</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Transfers in due to issuance of convertible promissory notes</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">28,521</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Transfers out due to conversions of convertible promissory notes</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Mark to market to November 30, 2019</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12,503</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Balance, November 30, 2019</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">16,018</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain on change in derivative liability for the three months ended November 30, 2019</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">12,503</td><td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Fluctuations in the Company&#8217;s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company&#8217;s balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company&#8217;s expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><b>Note 12. Subsequent Events</b></p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On December 30, 2019, The Company sold a convertible note to an accredited investor. The $63,000 note calls for annualized interest of 10% and is due on December 20, 2020. The note converts in common shares at 40% discount. This note is attached as an exhibit hereto.</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">On December 16, 2019, the Company&#8217;s board of directors by unanimous written consent caused the authorization of ten million (10,000,000) shares of preferred stock, par value $0.0001 per share, of the Company (&#34;Preferred Stock&#34;) in one or more series, and expressly authorized the Board of Directors of the Company (the &#34;Board&#34;), subject to limitations prescribed by law, to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock, and, with respect to each such series, to establish and fix the number of shares to be included in any series of Preferred Stock and the designation, rights, preferences, powers, restrictions, and limitations of the shares of such series.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;Additionally, the Board of Directors authorized the designation of eight million (8,000,000) preferred shares as &#8220;Series A Preferred Stock&#8221; and resolved to issue the Series A Preferred Stock to the directors of the corporation pro rata. The Series A Preferred Stock is not convertible into any other form of Securities, including common shares, of the Company. Holders of Series A Preferred Stock shall be entitled to fifty (50) votes for every Share of Series A Preferred Stock beneficially owned as of the record date for any shareholder vote or written consent. A copy of the Certificate of Designation is attached as an exhibit hereto.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 2, 2019, the Company signed an agreement to sell 260,000 registered common shares to an accredited investor. On November 26, 2019, the Company received $65,000 in advance of the signing agreement. The $65,000 was booked as a Stock Subscription Receivable. The underlying shares were issued during December of 2019 and will be reflected in the quarterly financial reporting period ending February 2020. See Note 7 to Financial Statements. The stock purchase agreement is attached hereto.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Stock-Based Compensation</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. We had no stock-based compensation during the year ended November 30, 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant components of the Company&#8217;s deferred tax assets at August 31, 2019 and November 30, 2019, are as follows:&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td>&#160;</td> <td colspan="3" style="text-align: center">November 30, 2019</td><td>&#160;</td> <td colspan="3" style="text-align: center">August 31, <br />2019</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 70%; text-align: left; padding-left: 9pt">Net operating loss carryforwards</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">385,437</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">212,618</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 9pt">Capitalized research and development</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">-------</font></td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 9pt">Research and development credit carry forward</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,963</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">1,963</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 27pt">Total deferred tax assets</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">387,400</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">214,581</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Less: valuation allowance</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(387,400</td><td style="text-align: left">)</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">(214,581</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 27pt">Net deferred tax asset</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of November 30, 2019 and August 31, 2019:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.5pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">November&#160;30,<br /> 2019</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Quoted<br /> Prices<br /> in Active<br /> Markets for<br /> Identical<br /> Assets<br /> (Level 1)</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Significant<br /> Other<br /> Observable<br /> Inputs<br /> (Level 2)</td><td style="padding-bottom: 1pt">&#160;</td> <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Significant<br /> Unobservable<br /> Inputs<br /> (Level 3)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Derivative liability</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">16,018</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">16,018</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> </table> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; color: white">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>August&#160;31,<br /> 2019</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>Quoted<br /> Prices<br /> in Active<br /> Markets for<br /> Identical<br /> Assets<br /> (Level 1)</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>Significant<br /> Other<br /> Observable<br /> Inputs<br /> (Level 2)</b></font></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif"><b>Significant<br /> Unobservable<br /> Inputs<br /> (Level 3)</b></font></td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 31%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">Derivative liability</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 15%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 21%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 12%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">$</font></td> <td style="width: 9%; text-align: right; line-height: 115%"><font style="font: 10pt/115% Times New Roman, Times, Serif; color: black">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td></tr></table> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The following table provides a summary of changes in fair value of the Company&#8217;s Level 3 financial liabilities for the three months ended November 30, 2019:</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 85%">Balance, August 31, 2019</td><td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Transfers in due to issuance of convertible promissory notes</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">28,521</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Transfers out due to conversions of convertible promissory notes</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Mark to market to November 30, 2019</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(12,503</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Balance, November 30, 2019</td><td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">16,018</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gain on change in derivative liability for the three months ended November 30, 2019</td><td>&#160;</td> <td style="text-align: left">$</td><td style="text-align: right">12,503</td><td style="text-align: left">&#160;</td></tr></table> 5000 0 5003 0 17931 2299 92636 152082 12550 13248 7200 7200 65000 0 217386 214829 197635 92806 1139 1139 0 5885 0 6250 35971 33334 16018 0 264855 153414 264855 153414 0 0 1483 1253 1464060 1184923 26 2840 -134953 -47469 61415 -152236 1 1226 1226 39 26 601825 601825 255605 -738004 -755287 -385437 217386 214829 17363 0 5003 0 5000 0 10003 0 2900 0 7103 0 1432 0 35883 0 148955 12500 187523 2261 373793 14761 -366690 -14761 31250 2522 12503 0 -18747 -2522 12752506 12257640 12257640 12257640 392155 260000 95670 95670 203333 20 74980 75000 26 64974 65000 20000 20000 188822 19 -19 260000 false EX-101.DEF 7 mctc-20191130_def.xml XBRL DEFINITION FILE EX-101.LAB 8 mctc-20191130_lab.xml XBRL LABEL FILE Legal Entity [Axis] Split Tee Related Party [Axis] Edward Manolos Dan Nguyen Legal Custodian Legal Custodian One Legal Custodian Two Long-term Debt, Type [Axis] Convertible Promissory Note Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Accredited Investor [Member] Equity Components [Axis] Class A Preferred Stock Common Stock Common Stock To Be Issued Additional Paid-In Capital Accumulated Deficit Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity a Shell Company? Is Entity's Reporting Status Current? Entity Filer Category Entity File Number Entity Common Stock, Shares Outstanding Entity Interactive Data Current Entity Incorporation, State or Country Code Document Fiscal Year Focus Entity Emerging Growth Company Entity Small Business Entity Ex Transition Period Statement of Financial Position [Abstract] ASSETS Current Assets: Cash Accounts Receivable Accounts Receivable - Related Party Inventory Total Current Assets Machinery & Equipment- Net Other Assets Note Receivable- Related Party Rent Deposit Stock Subscription Receivable TOTAL ASSETS LIABILITIES & STOCKHOLDER'S DEFICIT Current Liabilities: Accounts Payable Accounts Payable - Related Party Accrued Interest Accrued Professional and Legal Expenses Accrued Research and Development Expenses Convertible Notes, Net of Debt Discount of $17,363 and $0, respectively Derivative Liability Note Payable - Related Party Total Current Liabilities Total Liabilities Stockholder's Deficit Preferred Stock, par value $0.0001, 10,000,000 shares Authorized, 0 shares Issued and Outstanding at November 30, 2019 and August 31, 2019 Common Stock, par value $0.001, 290,000,000 shares Authorized, 14,833,128 shares Issued and Outstanding at November 30, 2019 and 12,713,129 at August 31, 2019 Additional Paid-In Capital Shares to be issued Accumulated Deficit Total Stockholder's Deficit TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT Convertible Notes, Debt Discount Current Preferred stock, par or stated value per share (in dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par or stated value per share (in dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues: Product Sales Consulting Revenue - Related Party Total Revenue Cost of Goods Sold Gross Profit Operating Expenses: Advertising fees Consulting services Professional fees General and administrative expense Total Operating Expenses Operating Loss Other Income (Expense) Interest expense Changes in FV of Derivative Total Other Income (Expense) Net Loss Basic & Diluted Loss per Common Share Weighted Average Common Shares Outstanding Statement [Table] Statement [Line Items] Beginning Balance, Shares Beginning Balance, Value Stock based compensation Proceeds from shares issued in private placement, Shares Proceeds from shares issued in private placement, Value Proceeds from shares issued in private placement- to be issued, Shares Proceeds from shares issued in private placement- to be issued, Value Discount on convertible note, Value Stock split adjustment, shares Stock split adjustment, Value Net Loss Ending Balance, Shares Ending Balance, Value Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Non-cash interest expense Depreciation expense Stock based compensation Change in fair value of derivative liability Changes In: Account Receivable Inventory Accounts Payable Accrued Interest Accrued Interest - Related Party Accrued Professional and Legal Expenses Accrued R&D Expenses Accounts Payable - Related Party Net Cash Used in Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES Net Cash Provided by Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of common stock Proceeds from convertible debentures Proceeds from Note Payable - Related Party Net Cash Provided by Financing Activities Net (Decrease) Increase in Cash Cash at Beginning of Period Cash at End of Period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid during the year for: Interest Cash paid during the year for: Franchise Taxes Accounting Policies [Abstract] Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements [Abstract] Going Concern Uncertainties Summary of Significant Accounting Policies Earnings Per Share [Abstract] Net Loss Per Share Notes to Financial Statements Notes Receivable - Related Party Debt Disclosure [Abstract] Note Payable to Shareholder Stock Subscription Receivable Related Party Related Party Income Tax Disclosure [Abstract] Income Taxes Convertible Note Payable Derivative Liability and Fair Value Measurements Subsequent Events [Abstract] Subsequent Events Derivative Instruments Consolidation Cash and Cash Equivalents Inventory Deposits Prepaid Expenses and Other Current Assets Accounts Receivable Property and Equipment, net Accounting for the Impairment of Long-Lived Assets Beneficial Conversion Feature Revenue Recognition Product Sales Costs of Revenues Stock-Based Compensation Income Taxes Loss Contingencies Net Income (Loss) Per Common Share Deferred income taxes Fair Value, Assets Measured on Recurring Basis Summary of changes in fair value of Level 3 financial liabilities Forward split Controlling interest description Deposits Allowance for doubtful accounts Impairment charges Stock-based compensation Income taxes Net loss Basic and diluted basis per common share Notes Receivable Interest rate Consulting fee Note Payable Interest Rate Common stock issued Advances Stock Subscription Receivable Notes Payable, Related Party Interest rate Gain on Debt Cancellation Conversion Price Conversion of Stock, Amount Converted Accrued interest Beneficial conversion feature Consulting revenue Deferred tax assets: Net operating loss carryforward Capitalized research and development Research and development credit carry forward Total deferred tax assets Less: valuation allowance Net deferred tax asset Net increase in the valuation allowance of deferred tax assets Operating loss carry forwards Operating Loss Carryforwards, Expiration Date Current tax expense Principal amount Warrants exercisable Exercisable Price Proceeds from Warrant Exercises Warrant expiration date Interest rate Interest expense Carrying value Debt discount Derivative liability Balance at beginning Transfers in due to issuance of convertible promissory notes Transfers out due to conversions of convertible promissory notes Mark to market Balance at end Gain on change in derivative liability Fair value of embedded derivatives Dividend yield Expected volatility Weighted average risk-free interest rate Expected life (in years) Estimated fair value of common stock Convertible debt Due date Assets, Current Assets Liabilities, Current Liabilities Additional Paid in Capital Retained Earnings (Accumulated Deficit) Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues Gross Profit Operating Expenses Operating Income (Loss) Interest Expense, Debt Nonoperating Income (Expense) Shares, Outstanding Share-based Payment Arrangement, Noncash Expense Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Interest Receivable, Net IncreaseDecreaseInAccruedProfessionalAndLegalExpenses Increase (Decrease) in Accounts Payable, Related Parties Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) StockSubscriptionReceivableTextBlock Long-term Debt [Text Block] Inventory, Policy [Policy Text Block] Receivable [Policy Text Block] ProductSalesPolicyTextBlock Income Tax, Policy [Policy Text Block] Deposit Assets StockSubscriptionReceivable Debt Instrument, Interest Rate, Increase (Decrease) Deferred Tax Assets, Gross Deferred Tax Assets, Valuation Allowance Deferred Income Tax Assets, Net Debt Instrument, Interest Rate During Period EX-101.PRE 9 mctc-20191130_pre.xml XBRL PRESENTATION FILE XML 10 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Nov. 30, 2019
Earnings Per Share [Abstract]      
Net loss $ (385,437) $ (17,283) $ (385,437)
Basic and diluted basis per common share $ (0.03) $ 0.00  
XML 11 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Liability and Fair Value Measurements (Tables)
3 Months Ended
Nov. 30, 2019
Notes to Financial Statements  
Fair Value, Assets Measured on Recurring Basis

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of November 30, 2019 and August 31, 2019:

 

   November 30,
2019
  Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
Derivative liability  $16,018   $-   $-   $16,018 
                     

 

    August 31,
2019
    Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
Derivative liability   $         -     $         -     $         -     $         -  
                                 
Summary of changes in fair value of Level 3 financial liabilities

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the three months ended November 30, 2019:

Balance, August 31, 2019  $- 
Transfers in due to issuance of convertible promissory notes   28,521 
Transfers out due to conversions of convertible promissory notes   - 
Mark to market to November 30, 2019   (12,503)
Balance, November 30, 2019  $16,018 
Gain on change in derivative liability for the three months ended November 30, 2019  $12,503 
XML 12 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Related Party (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 09, 2019
May 08, 2018
Nov. 26, 2019
Nov. 30, 2019
Nov. 30, 2018
May 31, 2018
Aug. 31, 2018
Aug. 31, 2019
Aug. 23, 2019
May 25, 2019
Notes Payable, Related Party       $ 14,000       $ 14,000    
Gain on Debt Cancellation       168,048            
Advances     $ 65,000              
Accrued interest       92       0    
Beneficial conversion feature         $ 27,954          
Notes Receivable       $ 40,000       $ 40,000    
Consulting revenue         $ 5,000          
Split Tee                    
Notes Receivable $ 20,000               $ 20,000  
Interest rate 10.00%                  
Consulting fee $ 5,000                  
Legal Custodian                    
Notes Payable, Related Party             $ 10,000      
Legal Custodian One                    
Notes Payable, Related Party             $ 35,554      
Interest rate             10.00%      
Conversion Price             $ 0.0001      
Conversion of Stock, Amount Converted   $ 13,000                
Legal Custodian Two                    
Notes Payable, Related Party             $ 600      
Interest rate           10.00%        
Advances           $ 600        
Accrued interest             $ 0      
Dan Nguyen                    
Note Payable                   $ 1,666,667
Interest Rate                   5.00%
Edward Manolos                    
Note Payable                   $ 1,666,667
Interest Rate                   5.00%
XML 13 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Going Concern Uncertainties
3 Months Ended
Nov. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern Uncertainties

Note 2. Going Concern Uncertainties

 

During recent financial reporting periods, the Company began reporting revenue and has been active in reorganizing its business operations, these revenues being generated are nominal. The Company has an accumulated deficit of $1,513,038 as of November 30, 2019, and does not have positive cash flows from operating activities. The Company expects to incur additional losses as it executes its business strategy in the cannabinoid marketplace. The Company will be subject to the risks, uncertainties, and difficulties frequently encountered by early-stage companies. The Company may not be able to successfully address any or all of these risks and uncertainties. Failure to adequately do so could cause the Company’s business, results of operations, and financial condition to suffer. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the issuance date of these financial statements.

The Company’s ability to continue as a going concern is an issue due to its net losses and negative cash flows from operations, and its need for additional financing to fund future operations. Management plans to obtain necessary funding from outside sources and through the sales of Company shares. There can be no assurance that such funds, if available, can be obtained on terms reasonable to the Company. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that may result from the outcome of this uncertainty.

Based on the Company’s current level of expenditures, management believes that cash on hand is not adequate to fund operations for the next twelve months. Management of the Company is estimating approximately $1,000,000 will be required over the next twelve months to fully execute its business strategy. These can be no assurance the Company will be able to obtain such funds.

XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Revenues:    
Product Sales $ 5,003 $ 0
Consulting Revenue - Related Party 5,000 0
Total Revenue 10,003 0
Cost of Goods Sold 2,900 0
Gross Profit 7,103 0
Operating Expenses:    
Advertising fees 1,432 0
Consulting services 35,883 0
Professional fees 148,955 12,500
General and administrative expense 187,523 2,261
Total Operating Expenses 373,793 14,761
Operating Loss (366,690) (14,761)
Other Income (Expense)    
Interest expense (31,250) (2,522)
Changes in FV of Derivative 12,503 0
Total Other Income (Expense) (18,747) (2,522)
Net Loss $ (385,437) $ (17,283)
Basic & Diluted Loss per Common Share $ (0.03) $ 0.00
Weighted Average Common Shares Outstanding 12,752,506 12,257,640
XML 15 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Details) - USD ($)
Nov. 30, 2019
Aug. 31, 2019
Deferred tax assets:    
Net operating loss carryforward $ 269,532 $ 212,618
Capitalized research and development 0 0
Research and development credit carry forward 1,963 1,963
Total deferred tax assets 271,495 214,581
Less: valuation allowance (271,495) (214,581)
Net deferred tax asset $ 0 $ 0
XML 16 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Liability and Fair Value Measurements (Details 1)
3 Months Ended
Nov. 30, 2019
USD ($)
Notes to Financial Statements  
Balance at beginning $ 0
Transfers in due to issuance of convertible promissory notes 28,521
Transfers out due to conversions of convertible promissory notes 0
Mark to market (12,503)
Balance at end 16,018
Gain on change in derivative liability $ 12,503
XML 17 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Liability and Fair Value Measurements
3 Months Ended
Nov. 30, 2019
Notes to Financial Statements  
Derivative Liability and Fair Value Measurements

NOTE 11 – DERIVATIVE LIABILITY AND FAIR VALUE MEASUREMENTS

 

Upon the issuance of certain convertible notes payable, the Company determined that the features associated with the embedded conversion option embedded in the notes payable should be accounted for at fair value, as a derivative liability, as the Company cannot determine if a sufficient number of shares would be available to settle all potential future conversion transactions.

 

At the issuance date of the convertible note payable, the Company estimated the fair value of the embedded derivatives of $28,521 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 398.53%, (3) weighted average risk-free interest rate of 1.60%, (4) expected life of three years and (5) estimated fair value of the Company’s common stock of $1.07 per share.

 

On November 30, 2019, the Company estimated the fair value of the embedded derivative of $16,018 using the Black-Scholes Pricing Model based on the following assumptions: (1) dividend yield of 0%, (2) expected volatility of 394.12%, (3) weighted average risk-free interest rate of 1.61%, (4) expected life of 2.94 years, and (5) estimated fair value of the Company’s common stock of $0.55 per share.

 

The Company adopted the provisions of ASC 825-10, Financial Instruments (“ASC 825-10”). ASC 825-10 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. ASC 825-10 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825-10 establishes three levels of inputs that may be used to measure fair value:

 

 ●Level 1 — Observable inputs that reflect quoted market prices (unadjusted) for identical assets and liabilities in active markets;

 

Level 2 — Observable inputs, other than quoted market prices, that are either directly or indirectly observable in the marketplace for identical or similar assets and liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities; and

 

Level 3 — Unobservable inputs that are supported by little or no market activity that are significant to the fair value of assets or liabilities.

 

All items required to be recorded or measured on a recurring basis are based upon Level 3 inputs.

 

To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement is disclosed and is determined based on the lowest level input that is significant to the fair value measurement.

 

The Company recognizes its derivative liabilities as Level 3 and values its derivatives using the methods discussed below. While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. The primary assumptions that would significantly affect the fair values using the methods discussed are that of volatility and market price of the underlying common stock of the Company.

 

As of November 30, 2019, the Company did not have any derivative instruments that were designated as hedges.

 

Items recorded or measured at fair value on a recurring basis in the accompanying financial statements consisted of the following items as of November 30, 2019 and August 31, 2019:

 

   November 30,
2019
  Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
  Significant
Other
Observable
Inputs
(Level 2)
  Significant
Unobservable
Inputs
(Level 3)
Derivative liability  $16,018   $-   $-   $16,018 
                     

 

    August 31,
2019
    Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
Derivative liability   $         -     $         -     $         -     $         -  
                                 

The following table provides a summary of changes in fair value of the Company’s Level 3 financial liabilities for the three months ended November 30, 2019:

Balance, August 31, 2019  $- 
Transfers in due to issuance of convertible promissory notes   28,521 
Transfers out due to conversions of convertible promissory notes   - 
Mark to market to November 30, 2019   (12,503)
Balance, November 30, 2019  $16,018 
Gain on change in derivative liability for the three months ended November 30, 2019  $12,503 

 

Fluctuations in the Company’s stock price are a primary driver for the changes in the derivative valuations during each reporting period. As the stock price increases for each of the related derivative instruments, the value to the holder of the instrument generally increases, therefore increasing the liability on the Company’s balance sheet. Additionally, stock price volatility is one of the significant unobservable inputs used in the fair value measurement of each of the Company’s derivative instruments. The simulated fair value of these liabilities is sensitive to changes in the Company’s expected volatility. Increases in expected volatility would generally result in higher fair value measurement. A 10% change in pricing inputs and changes in volatilities and correlation factors would not result in a material change in our Level 3 fair value.

EXCEL 18 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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̹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htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock Subscription Receivable
3 Months Ended
Nov. 30, 2019
Notes to Financial Statements  
Stock Subscription Receivable

Note 7. Stock Subscription Receivable

 

On November 26, 2019, the Company received $65,000 in advance related to the sale of 260,000 registered common shares to an accredited investor. While $65,000 was received on November 26, 2019, the agreement was not signed until December 2, 2019 and thus as of the end of the reporting period, November 30, 2019, the Company had not issued the 260,000 shares to the investors. The $65,000 was booked as a Stock Subscription Receivable. These underlying shares were issued during December of 2019 and will be reflected in the quarterly financial reporting period ending February 2020 and are listed herein in the Subsequent Events footnote.

ZIP 20 0001079974-20-000021-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001079974-20-000021-xbrl.zip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end XML 21 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Details Narrative) - USD ($)
3 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Aug. 31, 2019
Income Tax Disclosure [Abstract]      
Net increase in the valuation allowance of deferred tax assets $ 56,914    
Operating loss carry forwards $ 1,127,601    
Operating Loss Carryforwards, Expiration Date Aug. 31, 2039    
Current tax expense $ 0 $ 0  
Research and development credit carry forward $ 1,963   $ 1,963
XML 22 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 65 264 1 false 18 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://MCTC/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://MCTC/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://MCTC/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://MCTC/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT Sheet http://MCTC/role/CondensedConsolidatedStatementOfStockholdersDeficit CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Sheet http://MCTC/role/ConsolidatedStatementOfCashFlows CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Organization and Description of Business Sheet http://MCTC/role/OrganizationAndDescriptionOfBusiness Organization and Description of Business Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Uncertainties Sheet http://MCTC/role/GoingConcernUncertainties Going Concern Uncertainties Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://MCTC/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Net Loss Per Share Sheet http://MCTC/role/NetLossPerShare Net Loss Per Share Notes 10 false false R11.htm 00000011 - Disclosure - Notes Receivable - Related Party Notes http://MCTC/role/NotesReceivable-RelatedParty Notes Receivable - Related Party Notes 11 false false R12.htm 00000012 - Disclosure - Note Payable to Shareholder Sheet http://MCTC/role/NotePayableToShareholder Note Payable to Shareholder Notes 12 false false R13.htm 00000013 - Disclosure - Stock Subscription Receivable Sheet http://MCTC/role/StockSubscriptionReceivable Stock Subscription Receivable Notes 13 false false R14.htm 00000014 - Disclosure - Related Party Sheet http://MCTC/role/RelatedParty Related Party Notes 14 false false R15.htm 00000015 - Disclosure - Income Taxes Sheet http://MCTC/role/IncomeTaxes Income Taxes Notes 15 false false R16.htm 00000016 - Disclosure - Convertible Note Payable Sheet http://MCTC/role/ConvertibleNotePayable Convertible Note Payable Notes 16 false false R17.htm 00000017 - Disclosure - Derivative Liability and Fair Value Measurements Sheet http://MCTC/role/DerivativeLiabilityAndFairValueMeasurements Derivative Liability and Fair Value Measurements Notes 17 false false R18.htm 00000018 - Disclosure - Subsequent Events Sheet http://MCTC/role/SubsequentEvents Subsequent Events Notes 18 false false R19.htm 00000019 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://MCTC/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://MCTC/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - Income Taxes (Tables) Sheet http://MCTC/role/IncomeTaxesTables Income Taxes (Tables) Tables http://MCTC/role/IncomeTaxes 20 false false R21.htm 00000021 - Disclosure - Derivative Liability and Fair Value Measurements (Tables) Sheet http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsTables Derivative Liability and Fair Value Measurements (Tables) Tables http://MCTC/role/DerivativeLiabilityAndFairValueMeasurements 21 false false R22.htm 00000022 - Disclosure - Organization and Description of Business (Details Narrative) Sheet http://MCTC/role/OrganizationAndDescriptionOfBusinessDetailsNarrative Organization and Description of Business (Details Narrative) Details http://MCTC/role/OrganizationAndDescriptionOfBusiness 22 false false R23.htm 00000023 - Disclosure - Going Concern Uncertainties (Details Narrative) Sheet http://MCTC/role/GoingConcernUncertaintiesDetailsNarrative Going Concern Uncertainties (Details Narrative) Details http://MCTC/role/GoingConcernUncertainties 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://MCTC/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://MCTC/role/SummaryOfSignificantAccountingPoliciesPolicies 24 false false R25.htm 00000025 - Disclosure - Net Loss Per Share (Details Narrative) Sheet http://MCTC/role/NetLossPerShareDetailsNarrative Net Loss Per Share (Details Narrative) Details http://MCTC/role/NetLossPerShare 25 false false R26.htm 00000026 - Disclosure - Notes Receivable - Related Party (Details Narrative) Notes http://MCTC/role/NotesReceivable-RelatedPartyDetailsNarrative Notes Receivable - Related Party (Details Narrative) Details http://MCTC/role/NotesReceivable-RelatedParty 26 false false R27.htm 00000027 - Disclosure - Note Payable to Shareholder (Details Narrative) Sheet http://MCTC/role/NotePayableToShareholderDetailsNarrative Note Payable to Shareholder (Details Narrative) Details http://MCTC/role/NotePayableToShareholder 27 false false R28.htm 00000028 - Disclosure - Stock Subscription Receivable (Details Narrative) Sheet http://MCTC/role/StockSubscriptionReceivableDetailsNarrative Stock Subscription Receivable (Details Narrative) Details http://MCTC/role/StockSubscriptionReceivable 28 false false R29.htm 00000029 - Disclosure - Related Party (Details Narrative) Sheet http://MCTC/role/RelatedPartyDetailsNarrative Related Party (Details Narrative) Details http://MCTC/role/RelatedParty 29 false false R30.htm 00000030 - Disclosure - Income Taxes (Details) Sheet http://MCTC/role/IncomeTaxesDetails Income Taxes (Details) Details http://MCTC/role/IncomeTaxesTables 30 false false R31.htm 00000031 - Disclosure - Income Taxes (Details Narrative) Sheet http://MCTC/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://MCTC/role/IncomeTaxesTables 31 false false R32.htm 00000032 - Disclosure - Convertible Note Payable (Details Narrative) Sheet http://MCTC/role/ConvertibleNotePayableDetailsNarrative Convertible Note Payable (Details Narrative) Details http://MCTC/role/ConvertibleNotePayable 32 false false R33.htm 00000033 - Disclosure - Derivative Liability and Fair Value Measurements (Details) Sheet http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsDetails Derivative Liability and Fair Value Measurements (Details) Details http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsTables 33 false false R34.htm 00000034 - Disclosure - Derivative Liability and Fair Value Measurements (Details 1) Sheet http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsDetails1 Derivative Liability and Fair Value Measurements (Details 1) Details http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsTables 34 false false R35.htm 00000035 - Disclosure - Derivative Liability and Fair Value Measurements (Details Narrative) Sheet http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsDetailsNarrative Derivative Liability and Fair Value Measurements (Details Narrative) Details http://MCTC/role/DerivativeLiabilityAndFairValueMeasurementsTables 35 false false R36.htm 00000036 - Disclosure - Subsequent Events (Details Narrative) Sheet http://MCTC/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://MCTC/role/SubsequentEvents 36 false false All Reports Book All Reports mctc-20191130.xml mctc-20191130.xsd mctc-20191130_cal.xml mctc-20191130_def.xml mctc-20191130_lab.xml mctc-20191130_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 23 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Liability and Fair Value Measurements (Details Narrative) - Convertible Promissory Note - USD ($)
3 Months Ended
Nov. 06, 2019
Nov. 30, 2019
Fair value of embedded derivatives $ 28,521 $ 16,018
Dividend yield 0.00% 0.00%
Expected volatility 398.53% 394.12%
Weighted average risk-free interest rate 1.60% 1.61%
Expected life (in years) 3 years 2 years 11 months 8 days
Estimated fair value of common stock $ 1.07 $ 0.55
XML 24 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Convertible Note Payable
3 Months Ended
Nov. 30, 2019
Notes to Financial Statements  
Convertible Note Payable

Note 10 – Convertible Note Payable

 

On November 6, 2019, the Company issued a convertible promissory note in the principal amount of $20,000 along with 26,667 three-year warrants exercisable at $3.50 per share in exchange for proceeds of $20,000. The note matures May 6, 2020 and bears interest at the rate of 7% per annum, payable at maturity. Commencing thirty (30) days following the issuance date, the noteholder shall have the right to convert all or any part of the outstanding and unpaid principal balance of the note, at any time, into shares of common stock of the Company at a conversion price equal to the lower of (i) $0.75 per share; or (ii) 80% of the average of the previous twenty (20) trading day closing prices of the Company’s common stock, subject to adjustment. As a result of the issuance of the warrants as well as the beneficial conversion feature, upon issuance, the Company recognized total debt discount of $20,000, which is being amortized to interest expense over the term of the note. The Company is prohibited from effecting a conversion of the note to the extent that, as a result of such conversion, the noteholder, together with its affiliates, would beneficially own more than 4.99% of the number of shares of the Company’s common stock outstanding immediately after giving effect to the issuance of shares of common stock upon conversion of the note. As of November 30, 2019, the carrying value of the note was $2,637, net of debt discount of $17,363.

XML 25 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note Payable to Shareholder
3 Months Ended
Nov. 30, 2019
Debt Disclosure [Abstract]  
Note Payable to Shareholder

Note 6. Note Payable to Shareholders

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Payable, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

XML 26 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock Subscription Receivable (Details Narrative) - USD ($)
1 Months Ended
Nov. 26, 2019
Nov. 30, 2019
Aug. 31, 2019
Sep. 25, 2007
Notes to Financial Statements        
Common stock issued 260,000 14,833,128 12,713,129 1,000,000
Advances $ 65,000      
Stock Subscription Receivable $ 65,000      
XML 27 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Accounting Policies [Abstract]    
Deposits $ 0 $ 0
Allowance for doubtful accounts 0 0
Impairment charges 0 0
Stock-based compensation 0 0
Income taxes $ 0 $ 0
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
3 Months Ended
Nov. 30, 2019
Income Tax Disclosure [Abstract]  
Deferred income taxes

Significant components of the Company’s deferred tax assets at August 31, 2019 and November 30, 2019, are as follows: 

 

   November 30, 2019  August 31,
2019
Deferred tax assets:          
Net operating loss carryforwards  $385,437   $212,618 
Capitalized research and development   -------    - 
Research and development credit carry forward   1,963    1,963 
Total deferred tax assets   387,400    214,581 
           
Less: valuation allowance   (387,400)   (214,581)
           
Net deferred tax asset  $   $ 
XML 29 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document and Entity Information - shares
3 Months Ended
Nov. 30, 2019
Jan. 14, 2020
Document And Entity Information    
Entity Registrant Name MCTC Holdings, Inc.  
Entity Central Index Key 0001413488  
Document Type 10-Q  
Document Period End Date Nov. 30, 2019  
Amendment Flag false  
Current Fiscal Year End Date --08-31  
Document Fiscal Period Focus Q1  
Is Entity a Shell Company? false  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Non-accelerated Filer  
Entity File Number 000-27039  
Entity Common Stock, Shares Outstanding   15,093,128
Entity Interactive Data Current Yes  
Entity Incorporation, State or Country Code DE  
Document Fiscal Year Focus 2020  
Entity Emerging Growth Company true  
Entity Small Business true  
Entity Ex Transition Period false  
XML 30 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - USD ($)
Class A Preferred Stock
Common Stock
Common Stock To Be Issued
Additional Paid-In Capital
Accumulated Deficit
Total
Beginning Balance, Shares at Aug. 31, 2018 12,257,640      
Beginning Balance, Value at Aug. 31, 2018 $ 1 $ 1,226 $ 601,825 $ (738,004) $ (134,953)
Net Loss (17,283) (17,283)
Ending Balance, Shares at Nov. 30, 2018 12,257,640      
Ending Balance, Value at Nov. 30, 2018 $ 1,226 601,825 (755,287) (152,236)
Stock based compensation 95,670 95,670
Proceeds from shares issued in private placement, Shares 203,333      
Proceeds from shares issued in private placement, Value $ 20 74,980 75,000
Proceeds from shares issued in private placement- to be issued, Shares 260,000      
Proceeds from shares issued in private placement- to be issued, Value $ 26 64,974 65,000
Discount on convertible note, Value 20,000 20,000
Stock split adjustment, shares 188,822      
Stock split adjustment, Value $ 19 (19)
Net Loss (385,437) (385,437)
Ending Balance, Shares at Nov. 30, 2019 392,155 260,000      
Ending Balance, Value at Nov. 30, 2019 $ 39 $ 26 255,605 (385,437) (47,469)
Beginning Balance, Value at Aug. 31, 2019           61,415
Net Loss           (385,437)
Ending Balance, Shares at Nov. 30, 2019 392,155 260,000      
Ending Balance, Value at Nov. 30, 2019 $ 39 $ 26 $ 255,605 $ (385,437) $ (47,469)
XML 31 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies
3 Months Ended
Nov. 30, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 3.  Summary of Significant Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the amounts reported in those statements. We have made our best estimates of certain amounts contained in our consolidated financial statements. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. However, application of our accounting policies involves the exercise of judgment and use of assumptions as to future uncertainties, and, as a result, actual results could differ materially from these estimates. Management believes that the estimates, assumptions, and judgments involved in the accounting policies described below have the most significant impact on our consolidated financial statements.

 

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

 

Derivative Instruments 

The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense).

 

Our Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.

 

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.

 

Inventory

Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of November 30, 2019 and November 30, 2018, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.

 

Deposits

Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of November 30, 2019 or November 30, 2018.

 

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

 

Accounts Receivable

Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of November 30, 2019 and November 30, 2018, we had $0 and $0 allowance for doubtful accounts, respectively.

 

Property and Equipment, net

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”

 

Accounting for the Impairment of Long-Lived Assets

We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. We have not recorded any impairment charges related to long-lived assets during the quarter ended November 30, 2019, and November 30, 2018.

 

Beneficial Conversion Feature

If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.

 

Revenue Recognition

For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.

 

In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.

 

Product Sales

Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. Generally, we drop-ship orders to our clients with shipping-point or destination terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.

 

Costs of Revenues

Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

 

Stock-Based Compensation

Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. We had no stock-based compensation during the year ended November 30, 2019.

 

Income Taxes

We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending November 30, 2018, and November 30, 2019, we incurred no income taxes and had no liabilities related to federal or state income taxes.

 

Loss Contingencies

From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.

 

Net Income (Loss) Per Common Share

We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

XML 32 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Related Party
3 Months Ended
Nov. 30, 2019
Related Party  
Related Party

Note 8. Related Party

 

In October 2017 – August 31, 2018, the Company incurred a related party debt in the amount of $10,000 to an entity related to the legal custodian of the Company for professional fees. As of August 31, 2018, this balance was forgiven and was included as part of the $168,048 Cancellation of Debt Income on the Statement of Operations.

 

In November 30, 2017 – August 31, 2018, the Company issued a $35,554 in multiple notes payable to an entity related to the legal custodian of the Company. The notes payable bear interest at an annual rate of 10% and is convertible to common shares of the Company at $0.0001 per share. On May 8, 2018, $13,000 of the principal balance on notes payable were converted to common stock. The remaining principal balance was forgiven and included as Cancellation of Debt Income on the Income Statement for the year ended August 31, 2019.

 

In March 2018 and May 2018, a legal custodian of the Company funded the Company $600 in advances. On August 31, 2018, this amount was reclassified as a note payable, that bears interest at an annual rate of 10% and is payable upon demand.

 

In connection with the above notes, the Company recognized a beneficial conversion feature of $27,954, representing the intrinsic value of the conversion features at the time of issuance. This beneficial conversion feature was accreted to interest expense during the year ended August 31, 2018.

 

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen for loans made to the Company, each in the amount of $16,666,67 for a total balance of $33,334. The notes bear interest at 5% per annum and do not have a fixed payment schedule or maturity date. These notes are additionally described herein in Footnote 6 - Notes Payable.

 

On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

 

During the quarterly financial period ending November 30, 2019, the Company recorded $5,000 in consulting revenue associated with a Related Party, Edward Manolos. Mr. Manolos is a Related Party by way of his position as a director of the Company and due to his partial ownership of the contracted consulting organization to which services have been offered.

XML 33 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share
3 Months Ended
Nov. 30, 2019
Earnings Per Share [Abstract]  
Net Loss Per Share

Note 4. Net Loss Per Share

 

During the financial reporting period ending November 30, 2019, the Company recorded a net loss of $385,437, which equals a loss of $0.03 on both a basic and fully diluted basis, per common share.

XML 34 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Subsequent Events
3 Months Ended
Nov. 30, 2019
Subsequent Events [Abstract]  
Subsequent Events

Note 12. Subsequent Events

On December 30, 2019, The Company sold a convertible note to an accredited investor. The $63,000 note calls for annualized interest of 10% and is due on December 20, 2020. The note converts in common shares at 40% discount. This note is attached as an exhibit hereto.

On December 16, 2019, the Company’s board of directors by unanimous written consent caused the authorization of ten million (10,000,000) shares of preferred stock, par value $0.0001 per share, of the Company ("Preferred Stock") in one or more series, and expressly authorized the Board of Directors of the Company (the "Board"), subject to limitations prescribed by law, to provide, out of the unissued shares of Preferred Stock, for series of Preferred Stock, and, with respect to each such series, to establish and fix the number of shares to be included in any series of Preferred Stock and the designation, rights, preferences, powers, restrictions, and limitations of the shares of such series.

 Additionally, the Board of Directors authorized the designation of eight million (8,000,000) preferred shares as “Series A Preferred Stock” and resolved to issue the Series A Preferred Stock to the directors of the corporation pro rata. The Series A Preferred Stock is not convertible into any other form of Securities, including common shares, of the Company. Holders of Series A Preferred Stock shall be entitled to fifty (50) votes for every Share of Series A Preferred Stock beneficially owned as of the record date for any shareholder vote or written consent. A copy of the Certificate of Designation is attached as an exhibit hereto.

 

On December 2, 2019, the Company signed an agreement to sell 260,000 registered common shares to an accredited investor. On November 26, 2019, the Company received $65,000 in advance of the signing agreement. The $65,000 was booked as a Stock Subscription Receivable. The underlying shares were issued during December of 2019 and will be reflected in the quarterly financial reporting period ending February 2020. See Note 7 to Financial Statements. The stock purchase agreement is attached hereto.

XML 35 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Liability and Fair Value Measurements (Details) - USD ($)
Nov. 30, 2019
Aug. 31, 2019
Derivative liability $ 16,018 $ 0
Fair Value, Inputs, Level 1 [Member]    
Derivative liability 0 0
Fair Value, Inputs, Level 2 [Member]    
Derivative liability 0 0
Fair Value, Inputs, Level 3 [Member]    
Derivative liability $ 16,018 $ 0
XML 38 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Nov. 30, 2019
Aug. 31, 2019
Statement of Financial Position [Abstract]    
Convertible Notes, Debt Discount Current $ 17,363 $ 0
Preferred stock, par or stated value per share (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par or stated value per share (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized 290,000,000 290,000,000
Common stock, shares issued 14,833,128 12,713,129
Common stock, shares outstanding 14,833,128 12,713,129
XML 39 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Organization and Description of Business
3 Months Ended
Nov. 30, 2019
Accounting Policies [Abstract]  
Organization and Description of Business

Note 1. Organization and Description of Business

 

MCTC Holdings, Inc. is located at 520 S Grand Avenue, Suite 320, Los Angeles, California 90071. Our telephone number is (310) 986-4929 and our website is accessible at www.cannabisglobalinc.com. Our shares of Common Stock are quoted on the OTC Markets Pink, operated by OTC Markets Group, Inc., under the ticker symbol “MCTC.” We are a research and development company focused on cannabinoid research.

Our aim is to create and commercialize proprietary engineered technologies to deliver hemp extracts and cannabinoids to the human body. Additionally, we plan to develop consumer products, based on these and other proprietary technologies.

Our R&D programs included the following;

  1) Development of new routes and vehicles for hemp extract and cannabinoid delivery to the human body.

 

  2) Production of unique polymeric nanoparticles and fibers for use in oral and dermal cannabinoid delivery.

 

  3) Research and commercialization of new methodologies to isolate and/or concentrate various cannabinoids and other substances that comprise industrial hemp oil and other extracts.

 

  4) Establishment of new methods to increase the bioavailability of cannabinoids to the human body through utilization of proven bioenhancers, including d-α-Tocopherol polyethylene glycol 1000 succinate (TPGS), which is widely used as a water-soluble vitamin E formulation.

 

  5) Development of other novel inventions for the delivery of cannabinoids to the human body, which at this time are considered trade secrets by the Company.

 

On August 9, 2019, our board of directors determined the Company no longer meets the definition of a Shell Company as defined in Item 1101(b) of Regulation AB ( § 229.1101(b) of this chapter), which defines a Shell Company as one that has: 1) No or nominal operations; and 2) Either: (i) No or nominal assets; (ii) Assets consisting solely of cash and cash equivalents; or (iii) Assets consisting of any amounts of cash and cash equivalents and nominal other assets. By way of the Company: 1) beginning business activities and operations, 2) hiring its CEO, 3) appointing a highly experienced board of directors, 4) retaining consultants, 5) signing two property leases, 6) approval of budgets and business plans for several initiatives, 7) production of product samples, 8) sales initiatives to prospective customers, and other related business activities, the board of directors believes such activities are qualified as non-nominal operations and therefore the board of directors declared its believe the Company is no longer defined by Item 1101(b) of Regulation AB ( § 229.1101(b) of this chapter).

On August 9, 2019, the Company filed a DBA in California registering the operating name Cannabis Global. On July 1, 2019, the Company acquired Action Nutraceuticals, Inc., a company owned by our current CEO, Arman Tabatabaei. The transaction value was nominal, at only One Thousand Dollars ($1,000). Therefore, the Company believes its acquisition of Action Nutraceuticals, Inc. is not an acquisition of a significant amount of assets, or a transaction defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, that would require specific disclosures under the section cited. Regardless, the Company will disclose the transaction pursuant to 17 CFR § 229.404 - (Item 404) “Transactions with Related Persons, Promoters and Certain Control Persons.” No intellectual property, patents or trademarks were acquired in the transaction.

On July 1, 2019, the Company entered into a 100% business acquisition with Action Nutraceuticals, Inc., a company owned by our CEO, Arman Tabatabaei. The value of the transaction value was nominal, at only One Thousand Dollars ($1,000) thus, the Company believes the business acquisition of Action Nutraceuticals, Inc. is transaction NOT defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons that would require specific disclosure under the section cited. Regardless, of the requirements of 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, the Company makes this disclosure. 

On or about June 27, 2018 we changed domiciles from the State of Nevada to the State of Delaware and thereafter reorganized under the Delaware Holding Company Statute Delaware General Corporation Law Section 251(g). On or about July 12, 2018, two subsidiaries were formed for the purpose of effecting the reorganization. We incorporated MCTC Holdings, Inc. and MCTC Holdings Inc. incorporated MicroChannel Corp. We then effected a merger involving the three constituents and under the terms of the merger we were merged into MicroChannel Corp., with MicroChannel Corp. surviving and our separate corporate existence ceasing. Following the merger MCTC Holdings, Inc. became the surviving publicly traded issuer and all of our assets and liabilities were merged into MCTC Holdings, Inc.’s wholly owned subsidiary MicroChannel Corp. Our shareholders became the shareholders of MCTC Holdings, Inc. on a one for one basis.

On May 25, 2019, Lauderdale Holdings, LLC, a Florida limited liability company, in which former Chief Executive Officer, Garry McHenry maintains a controlling interest, sold 8,666,667 common shares of MCTC Holdings, Inc., representing approximately 70.7% of the 12,257,640 issued and outstanding shares to Messrs. Robert Hymers, Edward Manolos and Dan Nguyen, all of whom were previously unaffiliated parties. Each purchased 2,888,889 common shares for $108,333.33 each or an aggregate of $325,000, utilizing personal funds. This series of transactions constitute a change in control of the Company. The assets and liabilities of MicroChannel Corp. were spun out to Lauderdale Holdings, LLC as part of the change in control.

On January 14, 2009, Octillion Corp. (Symbol: OCTL), the parent company of MicroChannel announced that it had changed its name to New Energy Technologies, Inc. (Symbol: NENE) (“New Energy”). The name change became effective on the Over-the-Counter Bulletin Board at the opening of trading on January 14, 2009. On June 24, 2008, MicroChannel announced that it initiated trading of its stocks on the OTC Bulletin Board under the stock symbol “MCTC”. On August 22, 2007, by corporate action taken by MicroChannel’s executive team and board members, the company amended its Articles of Incorporation to increase its authorized capital stock to 300,000,000 million shares of common stock, $0.0001 par value per share. As of September 25, 2007, there were 1,000,000 shares of common stock were issued and outstanding; there were no preferred shares issued and outstanding. The directors and sole shareholder have approved a forward split of their issued and outstanding shares of common stock on the basis of 538,646 for 1 for the purpose of effecting the distribution.

On April 4, 2005, MultiChannel changed its name to MicroChannel Technologies Corporation. The Company’s original name was MultiChannel Technologies Corporation (“MultiChannel”) which was incorporated on February 28, 2005 under the laws of the State of Nevada (U.S.A.) and was originally formed as a wholly-owned subsidiary of Octillion Corp. (“Octillion”). Octillion (a Canadian company was trading in the OTC Markets under the symbol “OCTL”). At the time of Octillion’s existence, Octillion was a development stage technology company focused on the identificati0n, acquisition and development of emerging solar energy and solar related technologies and products.

XML 40 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Notes Receivable - Related Party (Details Narrative) - USD ($)
Jul. 09, 2019
Nov. 30, 2019
Aug. 31, 2019
Aug. 23, 2019
May 25, 2019
Notes Receivable   $ 40,000 $ 40,000    
Edward Manolos          
Note Payable         $ 1,666,667
Interest Rate         5.00%
Dan Nguyen          
Note Payable         $ 1,666,667
Interest Rate         5.00%
Split Tee          
Notes Receivable $ 20,000     $ 20,000  
Interest rate 10.00%        
Consulting fee $ 5,000        
XML 41 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Organization and Description of Business (Details Narrative) - $ / shares
1 Months Ended
May 25, 2019
Sep. 25, 2007
Nov. 30, 2019
Nov. 26, 2019
Aug. 31, 2019
Aug. 22, 2007
Accounting Policies [Abstract]            
Common stock, par or stated value per share (in dollars per share)     $ 0.001   $ 0.001 $ 0.0001
Common stock, shares authorized     290,000,000   290,000,000 300,000,000,000,000
Common stock, shares issued   1,000,000 14,833,128 260,000 12,713,129  
Common stock, shares outstanding   1,000,000 14,833,128   12,713,129  
Preferred stock, shares issued   0 0   0  
Preferred stock, shares outstanding   0 0   0  
Forward split   538,646 for 1        
Controlling interest description Lauderdale Holdings, LLC, a Florida limited liabiblity company, in which former Chief Executive Officer, Garry McHenry maintains a controlling interest, sold 8,666,667 common shares of MCTC Holdings, Inc., representing approximately 70.7% of the 12,257,640 issued and outstanding shares to Messrs. Robert Hymers, Edward Manolos and Dan Nguyen, all of whom were previously unaffiliated parties. Each purchased 2,888,889 common shares for $108,333.33 each or an aggregate of $325,000, utilizing personal funds. This series of transactions constitute a change in control of the Company. The assets and liabilities of MicroChannel Corp. were spun out to Lauderdale Holdings, LLC as part of the change in control.          
XML 42 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 43 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Nov. 30, 2019
Aug. 31, 2019
Current Assets:    
Cash $ 64,702 $ 152,082
Accounts Receivable 5,000 0
Accounts Receivable - Related Party 5,003 0
Inventory 17,931 2,299
Total Current Assets 92,636 152,082
Machinery & Equipment- Net 12,550 13,248
Other Assets    
Note Receivable- Related Party 40,000 40,000
Rent Deposit 7,200 7,200
Stock Subscription Receivable 65,000 0
TOTAL ASSETS 217,386 214,829
Current Liabilities:    
Accounts Payable 197,635 92,806
Accounts Payable - Related Party 1,139 1,139
Accrued Interest 92 0
Accrued Professional and Legal Expenses 0 5,885
Accrued Research and Development Expenses 0 6,250
Convertible Notes, Net of Debt Discount of $17,363 and $0, respectively 35,971 33,334
Derivative Liability 16,018 0
Note Payable - Related Party 14,000 14,000
Total Current Liabilities 264,855 153,414
Total Liabilities 264,855 153,414
Stockholder's Deficit    
Preferred Stock, par value $0.0001, 10,000,000 shares Authorized, 0 shares Issued and Outstanding at November 30, 2019 and August 31, 2019 0 0
Common Stock, par value $0.001, 290,000,000 shares Authorized, 14,833,128 shares Issued and Outstanding at November 30, 2019 and 12,713,129 at August 31, 2019 1,483 1,253
Additional Paid-In Capital 1,464,060 1,184,923
Shares to be issued 26 2,840
Accumulated Deficit (1,513,038) (738,004)
Total Stockholder's Deficit (47,469) 61,415
TOTAL LIABILITIES AND STOCKHOLDER'S DEFICIT $ 217,386 $ 214,829
XML 44 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Nov. 30, 2019
Nov. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Loss $ (385,437) $ (17,283)
Adjustments to reconcile net loss to net cash used in operating activities:    
Non-cash interest expense 31,158 0
Depreciation expense 698 0
Stock based compensation 116,553 0
Change in fair value of derivative liability (12,503) 0
Changes In:    
Account Receivable (10,003) 0
Inventory (15,632) 0
Accounts Payable 104,829 (1,070)
Accrued Interest 92 1,745
Accrued Interest - Related Party 0 777
Accrued Professional and Legal Expenses (5,885) 0
Accrued R&D Expenses (6,250) 0
Accounts Payable - Related Party 0 500
Net Cash Used in Operating Activities (182,380) (15,331)
CASH FLOWS FROM INVESTING ACTIVITIES    
Net Cash Provided by Investing Activities 0 0
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of common stock 75,000 0
Proceeds from convertible debentures 20,000 0
Proceeds from Note Payable - Related Party 0 15,356
Net Cash Provided by Financing Activities 95,000 15,356
Net (Decrease) Increase in Cash (87,380) 25
Cash at Beginning of Period 152,082 4,652
Cash at End of Period 64,702 4,677
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid during the year for: Interest 0 0
Cash paid during the year for: Franchise Taxes $ 0 $ 0
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Note Payable to Shareholder (Details Narrative)
May 25, 2019
USD ($)
Edward Manolos  
Note Payable $ 1,666,667
Interest Rate 5.00%
Dan Nguyen  
Note Payable $ 1,666,667
Interest Rate 5.00%
XML 46 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Going Concern Uncertainties (Details Narrative) - USD ($)
Nov. 30, 2019
Aug. 31, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accumulated Deficit $ (1,513,038) $ (738,004)
XML 47 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Nov. 30, 2019
Accounting Policies [Abstract]  
Derivative Instruments

Derivative Instruments

 

The fair value of derivative instruments is recorded and shown separately under current liabilities. Changes in the fair value of derivatives liability are recorded in the consolidated statement of operations under non-operating income (expense).

 

Our Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. For stock-based derivative financial instruments, the Company uses a weighted average Binomial option-pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

Consolidation

Consolidation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, Action Nutraceuticals, Inc. and Aidan & Co, Inc. All intercompany balances and transactions have been eliminated in consolidation.

Cash and Cash Equivalents

Cash and Cash Equivalents

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution.

Inventory

Inventory

Inventory is primarily comprised of work in progress. Inventory is valued at cost, based on the specific identification method, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to market value. As of November 30, 2019 and November 30, 2018, market values of all of our inventory were at cost, and accordingly, no such valuation allowance was recognized.

Deposits

Deposits

Deposits is comprised of advance payments made to third parties, primarily for inventory for which we have not yet taken title. When we take title to inventory for which deposits are made, the related amount is classified as inventory, then recognized as a cost of revenues upon sale (see “Costs of Revenues” below). There were no deposits as of November 30, 2019 or November 30, 2018.

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets is primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods which approximate the life of the contract or service period.

Accounts Receivable

Accounts Receivable

Accounts receivable are recorded at the net value of face amount less any allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and, based on a method of specific identification of any accounts receivable for which we deem the net realizable value to be less than the gross amount of accounts receivable recorded, we establish an allowance for doubtful accounts for those balances. In determining our need for an allowance for doubtful accounts, we consider historical experience, analysis of past due amounts, client creditworthiness and any other relevant available information. However, our actual experience may vary from our estimates. If the financial condition of our clients were to deteriorate, resulting in their inability or unwillingness to pay our fees, we may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that we collect retainers from our clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client's inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of November 30, 2019 and November 30, 2018, we had $0 and $0 allowance for doubtful accounts, respectively.

Property and Equipment, net

Property and Equipment, net

Property and Equipment is stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Depreciation of capitalized construction in progress costs, a component of property and equipment, net, begins once the underlying asset is placed into service and is recognized over the estimated useful life. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.”

Accounting for the Impairment of Long-Lived Assets

Accounting for the Impairment of Long-Lived Assets

We evaluate long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values or management's estimates, depending upon the nature of the assets. We have not recorded any impairment charges related to long-lived assets during the quarter ended November 30, 2019, and November 30, 2018.

Beneficial Conversion Feature

Beneficial Conversion Feature

If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). We record a BCF as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and we amortize the discount to interest expense over the life of the debt using the effective interest method.

Revenue Recognition

Revenue Recognition

For annual reporting periods after December 15, 2017, the Financial Accounting Standards Board (“FASB”) made effective ASU 2014-09 “Revenue from Contracts with Customers” to supersede previous revenue recognition guidance under current U.S. GAAP. Revenue is now recognized in accordance with FASB ASC Topic 606, Revenue Recognition. The guidance presents a single five-step model for comprehensive revenue recognition that requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Two options are available for implementation of the standard which is either the retrospective approach or cumulative effect adjustment approach. The guidance becomes effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period, with early adoption permitted. We determined to implement the cumulative effect adjustment approach to our implementation of FASB ASC Topic 606, with no restatement of the comparative periods presented. We intend to apply this method to any incomplete contracts we determine are subject to FASB ASC Topic 606 prospectively. As is more fully discussed below, we are of the opinion that none of our contracts for services or products contain significant financing components that require revenue adjustment under FASB ASC Topic 606.

 

In accordance with FASB ASC Topic 606, Revenue Recognition, we will recognize revenue when persuasive evidence of a significant financing component exists in our consulting and product sales contracts. We examine and evaluate when our customers become liable to pay for goods and services; how much consideration is paid as compared to the cash selling price of the goods or services; and, the length of time between our performance and the receipt of payment.

Product Sales

Product Sales

Revenue from product sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is shipped, and collectability is reasonably assured. Generally, we drop-ship orders to our clients with shipping-point or destination terms. For any shipments with destination terms, the Company defers revenue until delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant customer financing that would materially change the amount of revenue recognized under the sales transaction, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606.

Costs of Revenues

Costs of Revenues

Our policy is to recognize the costs of revenue in the same manner in conjunction with revenue recognition. Costs of revenues include the costs directly attributable to revenue recognition and include compensation and fees for services, travel and other expenses for services and costs of products and equipment. Selling, general and administrative expenses are charged to expense as incurred.

Stock-Based Compensation

Stock-Based Compensation

Restricted shares are awarded to employees and entitle the grantee to receive shares of restricted common stock at the end of the established vesting period. The fair value of the grant is based on the stock price on the date of grant. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which to date has been one year from the grant date. We had no stock-based compensation during the year ended November 30, 2019.

Income Taxes

Income Taxes

We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the quarterly reporting periods ending November 30, 2018, and November 30, 2019, we incurred no income taxes and had no liabilities related to federal or state income taxes.

Loss Contingencies

Loss Contingencies

From time to time the Company is subject to various legal proceedings and claims that arise in the ordinary course of business. On at least a quarterly basis, consistent with ASC 450-20-50-1C, if the Company determines that there is a reasonable possibility that a material loss may have been incurred, or is reasonably estimable, regardless of whether the Company accrued for such a loss (or any portion of that loss), the Company will confer with its legal counsel, consistent with ASC 450. If the material loss is determinable or reasonably estimable, the Company will record it in its accounts and as a liability on the balance sheet. If the Company determines that such an estimate cannot be made, the Company's policy is to disclose a demonstration of its attempt to estimate the loss or range of losses before concluding that an estimate cannot be made, and to disclose it in the notes to the financial statements under Contingent Liabilities.

Net Income (Loss) Per Common Share

Net Income (Loss) Per Common Share

We report net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

XML 48 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes
3 Months Ended
Nov. 30, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

Note 9. Income Taxes

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets at August 31, 2019 and November 30, 2019, are as follows: 

 

   November 30, 2019  August 31,
2019
Deferred tax assets:          
Net operating loss carryforwards  $385,437   $212,618 
Capitalized research and development   -------    - 
Research and development credit carry forward   1,963    1,963 
Total deferred tax assets   387,400    214,581 
           
Less: valuation allowance   (387,400)   (214,581)
           
Net deferred tax asset  $   $ 

 

The net increase in the valuation allowance for deferred tax assets was $172,819 for the three months ended November 30, 2019. The Company evaluates its valuation allowance on an annual basis based on projected future operations. When circumstances change and this causes a change in management’s judgment about the realizability of deferred tax assets, the impact of the change on the valuation allowance is reflected in current operations.

 

For federal income tax purposes, the Company has net U.S. operating loss carry forwards at November 30, 2019 available to offset future federal taxable income, if any, of $1,127,601 which will fully expire by the fiscal year ended August 31, 2039.  Accordingly, there is no current tax expense for the three months ended November 30, 2019. In addition, the Company has research and development tax credit carry forwards of $1,923 at November 30, 2019, which are available to offset federal income taxes and fully expire by November 30, 2039.

 

The utilization of the tax net operating loss carry forwards may be limited due to ownership changes that have occurred as a result of sales of common stock.

 

The effects of state income taxes were insignificant for the three months ended November 30, 2019 and November 30, 2018.

XML 49 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Notes Receivable - Related Party
3 Months Ended
Nov. 30, 2019
Notes to Financial Statements  
Notes Receivable - Related Party

Note 5. Notes Receivable – Related Party

 

On May 25, 2019, the Company issued two notes payable to Company directors Edward Manolos and Dan Nguyen, each in the amount of $16,666,67. The notes, which do not have a defined due date, outline a 5% per annum interest rate. These notes are additionally described herein in Footnote 5- Notes Receivable, Related Party and in the footnote outlining Related Party Transactions. These notes are additionally described herein in Footnote 6- Notes to Shareholders, Related Party and in the footnote outlining Related Party Transactions. Because of Mr. Manolos’ and Mr. Nguyen’s associations as directors, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

 

On July 9, 2019, the Company, through its Action Nutraceuticals subsidiary, loaned, Split Tee, LLC (“Split Tee”), a venture associated with Director Edward Manolos, $20,000 to engage in an exploratory research project. An additional $20,000 was supplied to Split Tee on August 23, 2019. The loans carry interest at the rate of 10% per annum and are due in one year for issuance. In addition, The Company, via Action Nutraceuticals subsidiary, invoiced Split Tee $5,000 as a consulting fee. Because of Mr. Manolos’ association as a director, the Company believes these transactions are defined by 17 CFR § 229.404 - (Item 404) Transactions with related persons, promoters and certain control persons, which would require specific disclosures under the section cited.

XML 50 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Convertible Note Payable (Details Narrative) - USD ($)
3 Months Ended
Nov. 06, 2019
Nov. 30, 2019
Interest expense   $ 20,000
Carrying value   2,637
Debt discount   $ 17,363
Convertible Promissory Note    
Principal amount $ 20,000  
Warrants exercisable 26,667  
Exercisable Price $ 3.50  
Proceeds from Warrant Exercises $ 20,000  
Warrant expiration date May 06, 2020  
Interest rate 7.00%  
XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended
Dec. 30, 2019
Nov. 26, 2019
Dec. 16, 2019
Dec. 02, 2019
Nov. 30, 2019
Aug. 31, 2019
Sep. 25, 2007
Preferred stock, par or stated value per share (in dollars per share)         $ 0.0001 $ 0.0001  
Preferred stock, shares authorized         10,000,000 10,000,000  
Common stock issued   260,000     14,833,128 12,713,129 1,000,000
Advances   $ 65,000          
Stock Subscription Receivable   $ 65,000          
Subsequent Event [Member]              
Preferred stock, par or stated value per share (in dollars per share)     $ 0.0001        
Preferred stock, shares authorized     10,000,000        
Subsequent Event [Member] | Accredited Investor [Member]              
Convertible debt $ 63,000            
Interest rate 10.00%            
Due date Dec. 20, 2020            
Subsequent Event [Member] | Series A Preferred Stock [Member]              
Preferred stock, shares authorized     8,000,000        
Common stock issued       260,000